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ABSTRACT 
  
DNA assembly and rational design are cornerstones of synthetic 
biology. While many DNA assembly standards have been published in 
recent years, only the Modular Cloning standard, or MoClo, has the 
advantage of publicly available part libraries for use in plant, yeast, and 
mammalian systems. No multipart modular library has previously been 
developed for use in prokaryotes. Building upon the existing MoClo 
assembly framework, we developed a collection of DNA parts and 
optimized MoClo protocols for use in E. coli. We present this assembly 
standard and library along with part characterization, design strategies, 
 vii 
 
potential applications, and troubleshooting. Developed as part of the 
Cross-disciplinary Integration of Design Automation Research (CIDAR) 
lab collection of tools, the CIDAR MoClo Library is publicly available and 
contains promoters, ribosomal binding sites, coding sequences, 
terminators, vectors, and a set of fluorescent control plasmids. Optimized 
protocols reduce reaction time and cost by >80% from previously 
published protocols. The CIDAR MoClo Library is the first bacterial DNA 
part library compatible with a multipart assembly standard.  
To demonstrate the utility of the CIDAR MoClo system in a 
traditional biology context, we used the library and previous expression 
data to create a series of dual expression plasmids. In this manner, we 
produced a dual expression plasmid capable of expressing equimolar 
amounts of two variants of rabbit aldolase, a His-tagged wildtype protein 
and a single-amino-acid substitution mutant deficient in binding actin. 
This expression plasmid will enable the production of dimer-of-dimer 
heterotetramers needed for structural determination of the actin-aldolase 
interaction by electron microscopy. To employ CIDAR MoClo in a 
synthetic biology context, we produced a bioelectronic pH-mediated 
genetic logic gate with DNA circuits built using MoClo and integrated with 
Raspberry Pi computers, Twitter, and 3D printed components. Logic 
gates are an increasingly common biological tool with applications in 
cellular memory and biological computation. MoClo facilitates rapid 
 viii 
 
iteration of genetic designs, better enabling the development of cellular 
logic.  
The CIDAR MoClo Library and assembly standard enable rapid 
design-build-test cycles in E. coli making this system advantageous for 
use in many areas of synthetic biology as well as traditional biological 
research.  
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1 CHAPTER 1 INTRODUCTION 
1.1 Synthetic biology 
Synthetic biology integrates engineering, biology, chemistry, and physics in 
a multidisciplinary research approach to biological engineering (Cameron et al. 
2014, Church et al. 2014). DNA assembly and modification is a cornerstone of the 
field, with applications ranging from cellular computation and memory devices to 
metabolic engineering and production of pharmaceuticals (Ro et al. 2006, Ham et 
al. 2008, Friedland et al. 2009, Bonnet et al. 2012, Keasling 2012). Increased 
modularity in genetic design in the form of publicly available libraries of 
characterized DNA parts provide a platform for rapid expression tuning of 
biological circuits (Casini et al. 2015). Likewise, the advent of affordable table top 
manufacturing is enabling new research approaches as 3D printing and computer 
numerical control (CNC) micromilling equipment and software tools become more 
available (O'Neill et al. 2014, Guckenberger et al. 2015).  
Recent examples of computation in living cells include genetic regulatory 
networks that count (Friedland et al. 2009) and a variety of approaches to creating 
Boolean logic in living cells (Tamsir et al. 2011, Siuti et al. 2013). Using 
recombinases enzymes which are able to cut DNA and invert the sequence, 
researchers created all 16 two-input logic gates in E. coli  with a single genetic 
module per gate (Siuti et al. 2013). Other logic gates designs have been produced 
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using common signaling pathways molecules in E. coli (Tamsir et al. 2011) and 
zinc-finger transcription factors in mammalian cells (Lohmueller et al. 2012).  
Synthetic biology has reoriented metabolic engineering, providing rational 
design tools for the modulation of biosynthesis and isolation of useful compounds 
(Salis 2011, Keasling 2012). A hallmark publication, the antimalarial medication, 
Artemisinin, was produced in yeast providing an alternative source of the high-
demand drug through a partnership with the Gates Foundation (Ro et al. 2006). In 
addition to biomedical applications, metabolic engineering is also being employed 
to produce high value molecules currently produced from petroleum (Lee et al. 
2012).  
Rapid DNA assembly forms the foundation of the design-build-test 
paradigm in synthetic biology across all of these applications. Despite 
improvements in the technologies, high throughput iterative designs and 
combinatorial methods are still cost prohibitive in a synthesis-based assembly due 
to the lack of reusable parts (Czar et al. 2009, Kosuri and Church 2014). As a 
result, a variety of DNA assembly standards based off a variety of methodologies 
have arisen in the previous 15 years to meet this demand.  
Multipart DNA assembly has become a common tool in genetic engineering 
methodologies since the publication of the Gibson and Golden Gate assembly 
methods (Engler et al. 2009, Gibson et al. 2009). While complex genetic designs 
can be built with synthesis-based assembly techniques, these methods produce 
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no standardized reusable parts and require novel synthesis for every iteration of 
design. The most efficient assembly method for a given application is largely 
application dependent.  
1.2 Assembly methodologies and standards 
Commonly used assembly methods are listed in Figure 1-1, part of a survey 
performed to determine the enabling technologies in synthetic biology (Kahl and 
Endy 2013). According to this survey, synthesis based methods including Gibson 
assembly (Gibson et al. 2009) are the most commonly used assembly methods 
followed closely by BioBrick (Knight 2007), Gateway (Katzen 2007), and BglBrick 
(Anderson 2010) assembly standards. Each of these methods are described 
further in this section.  
Gibson and synthesis based methods are ideal for many applications 
including genome engineering, but remain cost prohibitive for high throughput 
cloning and combinatorial assembly. Gateway cloning was one of the earliest 
standards developed, however it is primarily designed for moving full gene units. 
BioBrick and BglBrick standards offered the first modular DNA part assembly 
systems and libraries of basic parts (i.e. promoters, coding sequences), combining 
two parts at a time in a consuming binary fashion. 
 4 
 
 
Figure 1-1 Survey of enabling technologies: DNA assembly methods and standards. List of 
commonly used DNA assembly methods and standards as published by (Kahl and Endy 2013). 
Golden Gate and its derivatives, including Modular Cloning (MoClo), were 
the first multipart modular assembly standards available, allowing for the reliable 
assembly of up to 6 parts at a time (Engler et al. 2009, Weber et al. 2011). At the 
time this survey was taken, however, DNA part libraries were not yet widely 
available reducing the utility of these standards. In the past two years, part libraries 
have become increasingly available for eukaryotic MoClo platforms. This work 
describes the development of an E. coli MoClo assembly standard. With these part 
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libraries available, MoClo and related multipart assembly standards are rapidly 
becoming more widely used.  
DNA assembly standards can largely be broken down by the underlining 
methodology employed. In general, all assembly methods utilize one or more of 
the following tools; restriction endonucleases (RE), homing endonucleases (HE), 
Type IIS restriction endonucleases (Type IIS), or annealing overlapping ends (OE) 
(Casini et al. 2015). Assembly standards are further categorized by the ability to 
hierarchically assemble large constructs, to reuse parts with a modular design, and 
to assemble more than two parts in a single reaction. The most effective practices 
often utilize multiple assembly methods. 
1.2.1 Restriction endonucleases 
Restriction endonuclease (RE) digest and ligation techniques, traditional 
molecular biology methods, have been used to cut and paste DNA since the 1970s 
(Cohen et al. 1973). RE methods generally only join two DNA parts and are 
sensitive to illegal restriction sites, recognition sequences which may occur 
naturally within the sequence of the part and interfere with the cloning reaction. 
Complex DNA engineering with traditional cloning is an art form onto itself, 
requiring extensive planning and verification of intermediate steps.  
One of the first assembly standards developed, BioBricks (Knight 2007, 
Smolke 2009), uses standard RE methods with standard prefixes and suffixes 
each containing two restriction enzyme recognition sequences. BioBrick parts are 
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cut in a standard fashion resulting in a new part which contains the same prefix 
and suffix sequences while destroying the connecting restriction site. This allows 
for hierarchical assembly with a small number of enzymes.  
The brick-like assembly format is derived from the use of isocaudomers, 
restriction enzymes which recognize different sequences yet produce the same 
overhangs. When ligated, these overhangs produce ‘dead’ sites, sequences which 
are no longer recognized by either enzyme. These sites are referred to as ‘scars’ 
and are known to influence circuit behavior and stability (Sleight and Sauro 2013). 
BioBricks provided a foundation for standard, modular parts and gained traction as 
the method adopted by the International Genetically Engineered Machines 
competition (iGEM) (Smolke 2009).  
Though widely used, the BioBricks standard is limited by the binary nature 
of RE assembly methods. Parts are susceptible to illegal restriction sites and often 
require mutation of natural sequences for new parts. The binary nature of RE 
cloning assembly methods requires sequential step-by-step assembly increasing 
the time involved in the design-build-test cycle to produce iterative designs.  
1.2.2 Homing endonucleases 
Homing endonucleases (HE) function similarly to traditional restriction 
endonucleases but recognize longer sequences. This makes illegal sites unlikely. 
An early form of modular DNA assembly, HE methods first appeared with the 
Gateway cloning system commercialized by Invitrogen in the 1990s.  
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Gateway uses recombinases enzymes and long repetitive insertion 
sequences, att sites, to direct cloning. A concerted effort was made to create 
Gateway compatible plasmids carrying human, mouse, rat, and yeast open 
reading frames to support the research community (Gelperin et al. 2005, Nakajima 
et al. 2005, Giuraniuc et al. 2013). However, the att sites that grant modularity in 
Gateway cloning remain in the assembly as large scars between parts which can 
influence expression behavior (Chee and Chin 2015). 
Multiple HE assembly standards have arisen in recent years including an 
adaptation of the BioBrick standard termed iBrick (Liu et al. 2014) and the 
HomeRun Vector Assembly System (HVAS) based on a modified Gateway 
assembly standard (Li et al. 2014). These assembly systems also leave scars 
between assembled parts (i.e. residual modified or inserted sequences). In HE 
standards, the scars are generally larger than the BioBrick standard due to the 
increased size of the recognition sequence. 
1.2.3 Overlapping ends 
In order to streamline complex DNA assembly beyond the capabilities of 
traditional RE cloning, various methods rely on the annealing of complementary 
sequences by using parts with long overlapping ends to assemble intermediate 
parts (Horton et al. 1989, Bitinaite 2007, Gibson et al. 2009, Quan and Tian 2009, 
Annaluru 2012). Overlapping ends methods can be seamless or may use linker 
sequences leaving scars between parts in order to increase modularity. These 
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assembly methods are often used in concert with computer aided design tools to 
optimize assembly and design oligos automatically (Hillson et al. 2012, Appleton 
et al. 2014). 
Gibson assembly has become a common method in research laboratories 
with 48% of researchers surveyed reporting current use of the Gibson method 
(Kahl and Endy 2013). This scarless method allows for precision cloning of 
complex devices through synthesis of intermediate parts. However, though the 
cost of synthesis continues to decrease, Gibson and similar methods largely 
remain cost prohibitive for combinatorial assemblies and iterative design strategies 
(Kosuri and Church 2014).  
1.2.4 Type IIS restriction endonucleases 
An increasingly large collection of assembly standards relies upon Type IIS 
restriction endonucleases (Casini et al. 2015). These enzymes recognize non-
palindromic sequences and cut at a specific distance up or downstream of the 
recognition sequence. The first method published using these enzymes, Golden 
Gate (Engler et al. 2009), uses PCR products or stored plasmid DNA and two 
enzymes in a simultaneous one-pot digestion-ligation reaction. By reusing DNA 
parts, minimizing synthesis costs, Golden Gate formats tend to be less costly than 
Gibson assemblies.  
A variety of assembly standards have been published which utilize or modify 
the Golden Gate assembly strategy including Modular Cloning (Weber et al. 2011), 
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GoldenBraid (Sarrion-Perdigones 2011, Sarrion-Perdigones et al. 2013), BASIC 
(Storch et al. 2015), and yeast Golden Gate (yGG) (Agmon et al. 2015). 
Increasingly, combinations of assembly methods are being used to efficiently build 
complex DNA devices (Werner et al. 2012). This is the case with BASIC which 
combines overlapping ends and Type IIS enzymes to create an idempotent parts 
which are attached in a multipart single-tier assembly using linkers (Storch et al. 
2015).  
1.2.5 Modular cloning (MoClo) – Type IIS standard 
Of the assembly methods developed to date, only one, MoClo, has 
significant part libraries available for eukaryotic (Weber et al. 2011, Duportet et al. 
2014), yeast (Lee et al. 2015), plant systems (Engler et al. 2014) and now also for 
E. coli (Iverson et al. 2015). MoClo exploits user-defined overhangs specific to 
each part type such as a promoter or a coding sequence (CDS), thereby creating 
interchangeable DNA modules in the form of plasmids. This format allows for 
simple library propagation and combinatorial assembly from a library of reusable 
parts with reliable ligation of up to six DNA fragments in a one-pot reaction (Weber 
et al. 2011). 
The original MoClo publication described a complex system using two color 
and three antibiotic selection in a rotating hierarchical assembly standard (Weber 
et al. 2011). These protocols called for high concentrations of DNA and long 
reaction times (>5 hours) and were cost prohibitive (~$10 per reaction). In order to 
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be effective as a high throughput assembly standard in E. coli, a more efficient 
protocol was needed.  
Here we have optimized the published protocols, simplified the hierarchical 
assembly format, and created a library of reliable DNA parts for use in E. coli. The 
CIDAR MoClo Library described in Chapter 3 provides the first E. coli Type IIS 
compatible part library and is now available through Addgene (Iverson et al. 2015). 
This library enables rapid combinatorial assembly in bacteria and has practical 
applications in many fields including protein engineering, expression tuning, and 
library screening.  
To demonstrate the utility of the CIDAR MoClo Library outside of the 
synthetic biology community, we have collaborated with the Tolan lab in the 
Biology department at Boston University to tune the protein expression of two 
variants of the rabbit aldolase protein and enable isolation of the heterotetramers 
formed when these two variants are co-expressed. To employ CIDAR MoClo in a 
synthetic biology context, in Chapter 5 we produced a bioelectronic pH-mediated 
genetic logic gate with DNA circuits built using MoClo and integrated with 
Raspberry Pi computers, Twitter, and 3D printed components. An overview of 
these three chapters can be seen in Figure 1-2. 
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Figure 1-2 Overview of thesis. Chapter 3 describes the development and optimization of the 
CIDAR MoClo assembly standard and E. coli part library. Chapter 4 demonstrates the utility of this 
library and part characterization data to rationally design a equimolar dual expression cassette for 
production of heterotetrameric alodase proteins. Chapter 5 explores applications of the CIDAR 
MoClo assembly standard in devleoping bioelectronic cellular logic systems and incorporates 3D 
printing and computer numerical control (CNC) milling.  
1.3 Aldolase enzymatic and moonlighting functions 
Aldolase enzymes catalyzes an aldol reaction or its reverse. Two classes 
of aldolase have been identified with class I enzymes being cofactor-independent 
in catalyzing aldol reactions while class II enzymes employ a metal ion cofactor 
(Rutter 1964). Fructose-1,6-bisphosphate (Fru 1,6-P2) aldolase, referred to 
commonly and in this writing as simply ‘aldolase’, has a central role in fructose 
metabolism, glycolysis, and gluconeogenesis.  
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Aldolase catalyzes a reversible reaction that splits fructose 1,6-
bisphosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-
phosphate (G3P) (Horecker et al. 1980)(Figure 1-3a). Aldolase isozymes are 
further classified by expression in different tissues. Aldolase A, found in muscle, 
and aldolase C, found in brain, show higher efficiency for Fru 1,6-P2 versus 
fructose 1-phosphate (Fru 1-P) as these enzymes are primarily involved in 
gluconeogenesis and glycolysis. Aldolase B however shows equal efficiency for 
the two substrates corresponding to the importance of fructose metabolism in the 
liver where it is predominantly expressed (Penhoet and Rutter 1971). 
Monomeric and dimeric aldolase possess full catalytic activity (Beernink 
and Tolan 1994, Beernink and Tolan 1996), yet aldolase is found only as tetramers 
in vivo (Penhoet et al. 1967, Penhoet and Rutter 1971) with the exception of rare 
mutations which disrupt the dimer interface. Therefore the tetrameric form implies 
other functions for aldolase beyond the classical catalytic activity of the protein. 
With a dissociation rate of 10-25 M3 (monomer-tetramer equilibrium) (Tolan et al. 
2003), aldolase tetramers demonstrate an unusually stable formation compared to 
other glycolytic enzymes.  
Penhoet and Rutter (1971) dismissed the possibility of allosteric regulation 
with steady-state kinetic analysis showing no cooperativity. In a study 
demonstrating that the structure of the dimer and that of one hemisphere of the 
tetramer do not differ significantly, the researchers conclude that stability of the 
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tetramer suggest aldolase evolved as a ‘multimeric scaffold for non-catalytic 
functions’ (Sherawat et al. 2008). Supporting this assertion, class I aldolases 
display a high degree of amino acid conservation at both the active site and subunit 
interface residues (Rottmann et al. 1984, Rottmann et al. 1987, Sygusch et al. 
1987). 
The tetrameric form of aldolase has two distinct subunit interfaces; the A 
interface is hydrophobic while the B interface is hydrophilic (Sherawat et al. 
2008)(Figure 1-3b). Disruption of either interface by mutations at key sites leads 
to the dissociation of the tetramer into dimer form. These mutations do not, 
however, dramatically alter the tertiary structure of aldolase (Sherawat et al. 2008).  
A clinically relevant mutation, D128G, disrupts the B interface and has been 
associated with a rare nonspherocytic hemolytic anemia (Kishi et al. 1987). 
Aldolase with D128G or other mutations of this residue maintain catalytic activity 
with reduced thermostability and are found in dimer form. Mutations of Gln-125 
also disrupt the B interface while maintaining actin binding activity (Beernink and 
Tolan 1994).  
Dimer formation can also be seen with the disruption of the A interface by 
mutations at Glu-224 and Arg-258. Active monomers can be produced by 
disrupting the remaining interface with a second mutation as seen with the 
Q125D/E224A double mutant (Beernink and Tolan 1996). However, these 
monomers are not seen in vivo. 
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1.3.1 Moonlighting functions 
Consistent with the use of this tetramer as a scaffold, aldolase has been 
noted to moonlight in a variety of cellular processes. Many of these involve binding 
to F-actin, such as signal transduction, cell motility, and vesicle trafficking (Wang 
et al. 1996, Wang et al. 1997, Schindler et al. 2001, Ritterson Lew 2012). Known 
moonlighting interactions of actin are summarized in Figure 1-3c.  
Of particular interest, aldolase interacts with the thrombospondin-related 
Apicomplaxan protein (TRAP) family of transmembrane proteins found in the 
protozoan parasites responsible for malaria and toxoplasmosis (Sibley 2003). 
Aldolase forms a bridge between TRAP proteins and the actin cytoskeleton. This 
bridge allows the parasites to move, enabling infection (Jewett and Sibley 2003).  
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Figure 1-3 Aldolase function and moonlighting. (a) Aldolase function in 
glycolysis/gluconeogenesis. (b) Aldolase tertiary structure, tetramer. (c) Known protein interactions 
involving aldolase suggesting roles in signal transduction, motility, and vesicle trafficking.  
Previous research on the interaction between aldolase and actin proteins 
has determined that aldolase enzymatic activity and actin binding activity are 
independent. Mutations that affect enzyme activity do not hinder actin binding and 
vice versa (Wang et al. 1996). In particular, an arginine residue was substituted to 
create the R42A mutant aldolase which is catalytically active yet has a 20-fold 
decrease in affinity for F-actin. Conversely, the D33S variant retains affinity for F-
actin while being catalytically inactive (Wang et al. 1996).  
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1.3.2 Decorating F-actin 
Aldolase forms a scaffold for actin filaments, facilitating crosslinking 
(Schindler et al. 2001, Jewett and Sibley 2003, Pirani et al. 2004, Pirani 2008) 
(Figure 1-4a,b). The predominantly tetrameric aldolase offers two actin binding 
surfaces, functioning to crosslink actin filaments in non-symmetrical arrays making 
characterization of the binding interface difficult. An aldolase oligomer which 
creates symmetrical arrays is needed to decorate actin for structural determination 
of the binding interface by electron microscopy. 
The D128V aldolase mutant forms a dimer and functions as a scaffold for 
actin filaments without providing a second surface for crosslinking (Figure 1-4c). 
However, the symmetrical structure of the D128V dimer inhibits elucidation of the 
binding interface. A dimer-of-dimers in which only one dimer is able to crosslink 
could provide an appropriate aldolase-actin interaction for structure determination.  
A His-tagged wildtype rabbit aldolase (HRA) in a dimer-of-dimer formation 
with the R42A actin-binding-deficient aldolase variant may provide the structure 
needed for structure determination (Figure 1-4a,d). However, the N-terminal His-
tag appears to have a significant effect on protein expression such that duel 
expression of these otherwise nearly identical aldolase variants in the pETDuet 
expression plasmid produces HRA at a fraction of the level of R42A (Ho and Tolan, 
personal communication). High levels of protein expression of both variants is 
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needed to either produce predominately dimer-of-dimer heterotetramers in vivo or 
to create them in vitro through hybridizatoin.  
With the in vitro method for producing heterotetramers, isolated protein of 
each variant can be denatured to form monomers then mixed to produce all 
possible heterotetramers compositions. These are then separated by charge with 
chromatography on a salt gradient. However, loss of protein during renaturation 
and charge separation steps have thus far prevented significant production of 
dimer:dimer aldolase tetramers for structure characterization experiments.  
In order to produce predominately dimer-of-dimer heterotetramers in vivo, 
equimolar expression of these two variants is required in a single plasmid. 
Previous attempts at dual expression have resulted in an approximately 1:10 
difference in expression of R42A to HRA due, apparently, to the N-terminal His-
tag (Ho and Tolan, personal communications). To address this issue, we have 
used the CIDAR MoClo Library and previously gathered part characterization data 
to tune the expression of HRA and R42A and assemble a dual expression plasmid 
with approximately equimolar expression of HRA and R42A.  
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Figure 1-4 Aldolase HRA-R42A heterotetramers for decorating F-actin. (a) Aldolase CDS and 
protein monomer icon legend is shown. Wildtype aldolase has both traditional catalytic activity and 
actin-binding ability. His-tagged wildtype (HRA) retains both catalytic and actin-binding activity. 
R42A aldolase mutant retains catalytic activity while demonstrating a 20-fold decrease in actin-
binding activity. (b) Actin requires a scaffold upon which to structure filaments. Addition of µM 
wildtype aldolase provides a sufficient scaffold. As only a dimer is needed for scaffolding purposes, 
the stable wildtype tetramer creates crosslinked structures by providing two actin binding interfaces. 
(c) In comparison, the D128V disrupts the tetramer interface and this mutant exists predominately 
in dimer form. D128V dimers allow for actin scaffolding without crosslinking. However the 
symmetrical form of the dimer makes defining the actin binding interface difficult. (d) HRA-R42A 
heterotetramers may enable actin scaffolding while preventing crosslinking with a non-symmetrical 
aldolase complex. The charge difference between HRA and R42A should allow for the separation 
of different heterotetramers identifies. The species highlighted inside the black box are needed for 
actin-decorating. The bottom two-two heterotetramer is not expected to bind actin and will have no 
influence on downstream experiments.  
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1.4 Rational design of genetic circuits 
Rational design of biological devices, as described in 1.3.2, require well 
characterized parts and is facilitated by utilization of a standardized assembly 
format. Part libraries which better enable the rapid assembly of DNA devices are 
increasingly available and contain parts with known behaviors. In many cases 
while efforts have been made to compile libraries of parts, standard 
characterization methods and reliably predictably function parts are still lacking 
(Casini et al. 2015).  
1.4.1 Enhancing rational design capabilities 
In 2009, BIOFAB: International Open Facility Advancing Biotechnology 
(BIOFAB) was founded as a biological design-build-test facility. Researchers at the 
BIOFAB developed libraries of engineered constitutive and controllable promoters 
and translation elements (Mutalik et al. 2013a) and studied methods for accurately 
quantifying DNA part behavior (Mutalik et al. 2013b).  
These translation elements, termed bicistronic designs (BCDs), decouple 
transcription from translation by introducing an intermediate cistron between the 
promoter and the gene of interest. A 30 a.a. peptide is translated under the control 
of a standard ribosome binding sequence (RBS), and contains a stop codon and 
secondary RBS overlapping the start codon of the gene of interest. By disrupting 
the secondary structure between the promoter and second RBS, the use of a BCD 
was shown reduce variability in fluorescence expression 10-fold, from 16% to 1.6% 
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(Mutalik et al. 2013a). Three of these BCD parts, described in Chapter 3, were 
included in the CIDAR MoClo library to enable more rational design.  
Many methods of predicting protein expression and device behavior rely 
upon quantification of promoter and RBS sequences. Defining promoter 
sequences is often complicated as promoter components may be spread across 
hundreds of base pairs and controllable promoters (inducible/repressible) have an 
added factor of dose response to be considered. To approach this issue, 
researchers have proposed various methods for quantifying promoter (Beal et al. 
2012, Mutalik et al. 2013b). 
Most notable of these is the RBS calculator (Salis 2011)  created to provide 
a simple, accessible tool to aid in synthetic genetic design. The RBS calculator is 
an online tool which calculates theoretical RBS strength as a factor of secondary 
structure (https://salislab.net/software/) (Salis et al. 2009, Salis 2011). Other tools 
exist for more complex aspects of genetic design including Cello (Cellular Logic), 
a tool for designing cascading cellular logic from abstract specifications (Nielsen 
et al. 2016). 
1.5 Cellular logic; Boolean biology 
Cellular logic refers to the use of engineered circuits in living systems which 
can compute signals. The Voigt Lab at MIT has previously published a variety of 
transcriptional logic gates using inducible promoters and repressor proteins. One 
of these designs is shown in Figure 1-5. In order to create an XOR gate, cells 
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carrying specific plasmids were spotted in close proximity on media with or without 
inducer.  
 
Figure 1-5 XOR gate as an example logic gate. (a) Four different cell strains are required to 
isolate components of the logic gate. Extruded signaling molecules from the first strain act as 
inducers for the second level of strains in Cell 2 and Cell 3. Only in the presence of one or the other 
inducer molecule is the output, YFP, expressed. (b) pOR30 is the plasmid used in Cell 4 and also 
used in Chapter 5.  
These and other designs have demonstrated the potential for computational 
logic in cells (Friedland et al. 2009, Tamsir et al. 2011, Siuti et al. 2013). However, 
the need for compartmentalization of partial circuits in individual cells to prevent 
transcriptional cross talk is limiting. Some attempts to control crosstalk have looked 
to microfluidics to physically separate components of cellular logic. 
If these cellular logic and microfluidic designs could be miniaturized, 
automated, and integrated with an electronic system, more functional computation 
could be seen. The Cello software tool aids the design of computational logic within 
cellular systems by defining cascades built from a library of genetic logic gates, 
fulfilling the need for automation (In press, Science 2015). Meanwhile, CNC milling, 
3D printing and open source electronics systems could serve to provide the 
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miniaturization and bioelectronic integration aspects and lay the groundwork for 
more functional cellular computing.  
1.6 Bioelectronic synthetic biology; CNC milling, 3D printing and adaptive 
research tools 
Additive and subtractive manufacturing are increasingly affordable tools for 
synthetic biology. Tabletop 3D printers and computer numerical control (CNC) mills 
are commercially available in the range of $900-$2200. Free and open source 
software tools, such as OpenSCAD (www.openscad.org/) and Blender 
(https://www.blender.org/), facilitate the rapid design and iteration of increasingly 
complex microfluidics and custom tools (Gutierrez-Arenas 2015, Oxman 2015).  
3D printing is particularly useful for designing custom devices and housings 
for electronic systems, as is the case with the syringe pump designed at MIT 
(Wijnen et al. 2014). This syringe pump provides an affordable alternative to 
commercially available injection devices and can be controlled electronically with 
open source devices. Examples of 3D printing and CNC milling in synthetic biology 
can be seen in Figure 1-6.  
Integration of these tools, MoClo, 3D printing, CNC milling, and affordable 
electronics, opens the door for a wide range of bioengineered tools. Since all 
components of these designs are easily accessible and affordable, designs can be 
placed online and replicated anywhere in the world.  
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Figure 1-6 CNC and 3D printing in synthetic biology. Examples of 3D printing and CNC milling 
in synthetic biology include (a) an open source 3d printed turbidostat, (b) an open source library of 
3d printed syringe pumps, and (c) various CNC micromilling methods for microfluidics. Additionally, 
online design tools like 3DµF (cidarlab.github.io/3DuF/) enable intuitive simple design of 3 
dimensional objects with a standard .stl file format which is easily interchanged between tools.  
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2 CHAPTER 2 MATERIALS AND METHODS 
2.1 General supplies and reagents 
PCR performed using Phusion polymerase (NEB Cat #M0530L). Plasmid 
preparations and PCR cleanup were done using Qiagen Plasmid Mini Prep 
(Qiagen Cat #12125) and Qiagen Qiaquick PCR Purification Kit (Qiagen Cat 
#28106) following the manufacturers protocols. Transformations were performed 
with 6-15 μL of Alpha Select Gold Efficiency E. coli cells (Bioline USA Inc., 
Taunton, MA, USA) with a standard heat shock protocol (incubate on ice with DNA 
5’, 42°C 90”, return to ice and recover in LB or SOC media).  
2.2 Bacterial culturing and DNA handling 
2.2.1 Bacterial strains, growth and storage conditions 
For general cloning, Alpha Select Gold Efficiency DH5α E. coli cells (Bioline 
USA Inc., Taunton, MA, USA) were used in volumes of 5-10 µL per transformation. 
All plasmids are stored in these cells as glycerol preps and generally these are the 
cultures used in plasmid preps for sequencing and for use in MoClo reactions.  
Cells were plated on appropriate antibiotic selective LB agar, supplemented 
with 80 μL of 20 mg/μL 5-bromo-4-chloro-3-indolyl ß-D-galactopyranoside (X-GAL) 
and 100 μL of 0.1M isopropyl-ß-D-thiogalactopyranoside (IPTG) (Zymo Research 
Corp., Irvine, CA, USA). Blue-white screening was used to select colonies which 
were grown overnight at 37°C in LB supplemented with the appropriate antibiotic. 
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In Chapter 5, Top10 (DH10B derived) cells were used in some experiments 
as noted in specific chapters.  
2.2.2 Plasmid nomenclature 
Plasmid names are abbreviations of the component parts as follows 
(Figure 2-1). pJ02B2Rm_AE(A) or pR404mGm_EF(K). In this format, “p” indicates 
“plasmid” verses describing the insert alone. The next three characters are 
generally a capital letter and two numbers identifying the promoter. In these 
examples, J02 = J23102 and R40 = R0040, both BioBrick parts. The next two or 
three digits identify the RBS or RBS type part which through this writing will be one 
of six parts. “2m”, “3m”, “4m” refer to the Weiss RBS parts from the BioBrick 
registry, B0032, B0033, and B0034; “m” indicates the parts have been modified 
and these parts contain the flanking BioBrick scar sequences to maintain the 
original BioBrick spacing. “B2”, “B8” and “B12” refer to three of the BIOFAB 
bicistronic design elements, BCD2, BCD8 and BCD12 which are cloned as _BC 
parts and treated as RBS part types for cloning purposes though they actually 
contain a small coding sequence and second RBS site.  
The characters between the RBS designation and the “_” indicate the 
coding sequence. Commonly these are seen as “Rm” or “Gm” indicating a red 
fluorescent protein (RFP) or green fluorescent protein (GFP) coding sequence. 
Here “m” indicates a modification from the original sequence usually pertaining to 
the removal of one or more illegal restriction endonuclease recognition sequences. 
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The capital two letter code after the underscore denote the 5’ and 3’ fusion sites, 
respectively. The B0015 terminator sequence is used for all plasmids discussed in 
these works and is not denoted in the plasmid name. The capital letter in 
parenthesis at the end indicates the antibiotic resistance of the vector used, either 
ampicillin (A), kanamycin (K) or chloramphenicol (C). 
 
Figure 2-1 CIDAR MoClo plasmid nomenclature. Plasmids are given unique names with 
descriptive abbreviations to allow for simple identification. Grey part symbols are used to indicate 
a generic part type rather than a specific part. 
When describing a generic part within a plasmid, an X is used as a wildcard 
to indicate this part is not specifically designated. For example, pJXB2Rm_AE 
would describe any plasmid or a collection of plasmids which have a J23 series 
 27 
 
promoter, BCD2, and E1010m (RFP) in an _AE vector. Similarly, in all figures grey 
symbols indicate an undefined part. Using this nomenclature, pJ02B2Rm_AE(A) 
can be easily identified as a transcription unit containing J23102, BCD2, E1010m 
(RFPm), and B0015 in that order cloned into the DVA_AE vector which carries the 
ampicillin resistance gene, bla. 
Lists of plasmids with component parts explicitly described are found in 
Table A-7. 
2.2.3 Basic part and vector preparation & validation 
Plasmid prep cultures were grown up overnight in 3-5 mL of LB with 
appropriate antibiotic or grown for 6-8 hours during the day in instances where 
same day sequencing was needed. 
2.2.3.1 Basic parts general cloning strategy  
Basic parts were either amplified from plasmids obtained from BioBricks 
(http://partsregistry.org/) or Addgene (Addgene.org, Cambridge, MA, USA) or, if 
the part was less than 35 bp, were assembled using annealing oligonucleotides 
containing the appropriate fusion sites and BsaI restriction sequences. PCR 
reactions were performed as above. Complimentary oligonucleotides were heated 
to 95°C and cooled at a rate of 0.5°C/minute to a final temperature of 45°C before 
being diluted for use in a MoClo reaction as above. This PCR product or annealed 
DNA was then used in a Level 0 or Basic Part MoClo reaction as described below 
and in Figure 3-1.  
 28 
 
2.2.3.2 Destination vectors 
The lacZ alpha fragment was PCR amplified pMJS2AF (donated by Dr. 
Michael Smanski) and subsequently cloned into two backbones: DVA vectors used 
pSB1A2, DVK vectors used pSB1K3. DNA containing the lacZ alpha fragment was 
used as template for PCR reactions (20 fmol). PCR reactions with Phusion DNA 
polymerase (NEB) following the manufacturer’s protocol and  were performed as 
follows: denaturation at 95°C for 1’, 30 extension cycles  (98°C 20”, 61°C 20”, 72°C 
20”), 5’ extension at 72°C, hold 4°C. PCR product was gel extracted and cleaned 
using QIAquick PCR Purification Kits (Qiagen Inc., Valencia, CA, USA). 
LacZ PCR products and pSB1K3 and pSB1A2 vectors were digested with 
SpeI enzyme (NEB) according to the manufacturer’s protocol, cleaned up using 
the QIAquick PCR Purification Kit (Qiagen). Ligation reactions used T4 DNA ligase 
(NEB). Cells were plated on appropriate antibiotic selective LB agar, supplemented 
with 80 μL of 20 mg/μL 5-bromo-4-chloro-3-indolyl ß-D-galactopyranoside (X-GAL) 
and 100 μL of 0.1M isopropyl-ß-D-thiogalactopyranoside (IPTG) (Zymo Research 
Corp., Irvine, CA, USA). Blue colonies were selected and sequence verified.  
DVL2 carried an illegal BsaI site in the bla ampicillin resistance gene, which 
was fixed with PCR mutagenesis as described in Weber et. al (2011) to create a 
new vector, DVA.  
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2.2.3.3 Transcription Unit (Level 1) and Device (Level 2) assembly 
Transcription units, generally consisting of a promoter, RBS part, CDS, and 
terminator assembled in a DVL1 / DVK vector, and Devices, multiple transcription 
units combined in a DVL2 / DVA vector, were assembled using the MoClo 
protocols as described in 2.3.  
2.2.3.4 Plasmid isolation and sequence analysis  
Plasmids were purified using the QIAprep Spin Miniprep kit (Qiagen) 
following the manufacturers’ protocols. Sequences were validated with the 
standard BioBrick vector primers, Vector Forward (VF2) (5’-tgccacctgacgtctaagaa-
3’) and Vector Reverse (VR) (5’-attaccgcctttgagtgagc-3’) primers. In larger 
constructs internal primers were used to sequence verify on a case by case basis. 
Sequences were analyzed using Benchling (www.benchling.com). 
2.2.4 DNA parts construction 
In total, ### parts were constructed for use in the CIDAR MoClo assembly 
standard. The initial CIDAR collection consisted of ## basic parts built in DVL0 
(Chloramphenicol) vectors derived from pSB1C3 (BioBrick Part Registry) and ## 
destination vectors (DVL0, DVL1, and DVL2). These parts were used in optimizing 
MoClo protocols and building most of the transcription units described in this 
thesis. The final CIDAR MoClo standard and library replaces the DVL0 vectors 
with DVA vectors (DVL2 with repaired illegal site) and many basic parts were 
recloned into DVA vectors for the final published CIDAR library.  
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2.2.4.1 Initial 3 antibiotic CIDAR part collection 
The initial CIDAR parts collection consisted of BioBrick parts converted to 
MoClo format in a destination vector carrying chloramphenicol resistance, DVL0, 
derived from the BioBrick vector pSB1C3. The parts were chosen for their utility 
and verified function within the iGEM Parts Registry.  
All promoters and the B0015 terminator were cloned as four variations with 
appropriate fusion sites as described in Figure 3-1. Including both basic parts and 
destination vectors, 128 plasmids were cloned, verified, and archived as the initial 
CIDAR MoClo collection. All information about these parts was recorded and 
maintained in the CIDAR Registry, a detailed excel file. Approximately 18% of 
these parts were cloned by the 2012 and 2013 BostonU iGEM teams and other 
members of the CIDAR lab. A list of these parts is found in Table A-6. Primer 
design used in assembly are noted in Table A-4. 
2.2.4.2 Final CIDAR collection and CIDAR MoClo Library 
In order to increase efficiency of cloning and increase plasmid yield, all of 
the basic parts to be used in the CIDAR MoClo Library were converted from the 
DVL1 (Chloramphenicol, CAM) backbone to the DVA (Ampicillin, AMP, backbone 
with repaired illegal site). DVA provided higher plasmid DNA concentrations 
(average ~100 ng/µL verses ~20 ng/µL) and simplifies the library system by 
removing CAM plasmids from the rotation. Level 0 (Basic Parts) and Level 2 
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(Devices) both use DVA vectors minimizing the number of assembly vectors 
required. 
While preparing the CIDAR MoClo Library, 6 coding sequence parts were 
cloned a second time to replace incorrect sequences or to remove illegal sites. A 
total of 17 new DVA vectors were created as well as the DVK_AF vector to allow 
for vector context comparison of two-part Devices. Additionally, empty DVA and 
DVK vectors were cloned, closed on a SpeI site and lacking the LacZ cassette and 
fusions sites to enable the production of new vectors. 
2.3 CIDAR MoClo assembly methods 
2.3.1 Original and Optimized MoClo Protocols 
Initial MoClo assembly reactions followed the previously published protocol 
(Weber et al. 2011), using 45 cycles alternating between 37°C 2’ and 16°C 5’ 
followed by 50°C 5’ and 80°C 10’ with 40 fmol of each DNA part, 10 U of restriction 
enzyme, 10 U of T4 ligase (Promega) with 1x Promega T4 ligase buffer in a 20 µL 
volume.  
In developing optimal protocols, various reaction conditions were tested. 
The following components were added to a 0.2 mL tube: 10-60 fmol of each DNA 
component with up to six components total using equimolar PCR product or 
previously made MoClo DNA parts, and the appropriate Destination Vector, 10-50 
U of BsaI or BbsI (NEB), 5-50 U of T4 DNA ligase (Cat #M1794, Promega, 
Madison, WI, USA or #M0202 NEB), 1 X T4 DNA Ligase Buffer (Promega or NEB), 
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and sterile, deionized water to at total volume of 10-60 µL. Reactions were 
performed using the following parameters: 15-40 cycles (37°C 1.5-3’, 16°C 3-5’), 
followed by 50°C for 5’ and 80°C for 10’ then held at 4°C or -20°C until transformed.  
By comparing efficiencies and costs, the optimal protocol was determined 
as follows: 10 fmol of each DNA component, 10 U of BsaI or BbsI, 20 U of T4 
Ligase (NEB or Promega) and 1x T4 DNA Ligase Buffer (Promega only) to a final 
volume of 10-20 µL depending on concentration of DNA parts. Lower volumes are 
preferred.  
2.3.2 Multiplex MoClo Protocols 
MoClo reactions were prepared as above with the following differences: The 
multiplex part type(s) was added such that the total concentration of that type was 
equimolar to the other part types. When multiplexing less than 6 of any one part 
type, samples were pipetted individually. To accommodate accurate 
measurements, multiplex reactions were performed in 20 µL volumes with 60 fmol 
of each part type. For example, in a reaction using 6 different promoters, 10 fmol 
each of these promoters was used along with 60 fmol of each other part. For larger 
multiplex examples all iterations of a given part type are mixed in equimolar ratio 
prior and added as one mixed part.  
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2.4 Fluorescence analysis 
2.4.1 Flow cytometry 
All fluorescent expression devices were characterized using a BD 
LSRFortessa SORP flow cytometer. RFP fluorescence was measured using a 
solid-state Coherent Sapphire 561 nm laser at 100 mw strength with a PE-Texas 
Red 610/20 filter. GFP fluorescence was measured using a solid-state Coherent 
Sapphire 488 nm laser at 200 mw strength with a FITC 530/30 filter. Clonal 
colonies were grown overnight on agar with antibiotic and were used to inoculate 
200 µL LB broth (Sigma-Aldrich) with the appropriate antibiotic in sterile 96-deep 
well plates in triplicate grown for 16 hours,37°C shaking, 300 rpm. Cells were then 
diluted 100-fold into 200 µL of sterile phosphate buffered saline (PBS) in 96-well 
round bottom plates before measurement. 
2.4.2 Plate reader for optical density and fluorescence measurements 
A Tecan SpectraFluor Plus plate reader with Magellen v6.6 software was 
used for optical density (OD or OD600) measurements and to measure 
fluorescence in culture. Measurements were performed in 96-well plates with 200 
µL volumes. For OD, default settings were used along with blank wells to provide 
background subtracted data. For fluorescence, top and bottom read options were 
used as noted with manual gain and filter settings as follows: RFP – ex. 580 / em. 
635, gain 87. GFP – ex. 485 / em. 535, gain 89.  
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2.4.3 Two color control array and color model 
In order to create an accurate color model, a series of high and low 
expression RFP and GFP transcription units, described here as two-color controls 
were evaluated by flow cytometry as in 2.4.1. These TUs were assembled in _AE 
and _EF DVK, transferred to DVA, and assembled into dual expression devices in 
_AF DVA vectors. This series was designed to provide both the _AE and _EF 
context for each TU as well as both variants of dual expression plasmids for each. 
A subset of eBFP2 transcription units were also assembled as part of this series 
for comparison. A complete list of these two-color control plasmids is included in 
Table 2-1.  
The two-color controls were measured by flow cytometry in triplicate, 
overnight cultures diluted 1:100 in PBS and measured as described in 2.4.1. In 
order to normalize to fluorescein, one color used in the model must register with 
the FITC filter set (generally either YFP or GFP). For this color model, designed 
for use primarily with red and green fluorescence, GFP and RFP constructs were 
used to build the color model.  
To enable normalization, expression of each fluorescent reporter needed to 
be high enough to register cleanly on all appropriate fluorescence channels. This 
initial flow cytometry data identified J02B2 as the promoter/RBS combination ideal 
for use as the color model due to its consistently high level of expression in different 
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constructs. A small number of eBFP2 transcription units were made to test ability 
of a RFP:GFP color model to predict expression in another filter set. 
Plasmid ID 2CC# Construct 
pJ02B2Rm_AE(K) 2CC01 J23102:BCD2:RFP:B0015 
pJ02B2Gm_EF(K) 2CC02 J23102:BCD2:GFP:B0015 
pJ02B12Rm_AE(K) 2CC03 J23102:BCD12:RFP:B0015 
pJ02B12Gm_EF(K) 2CC04 J23102:BCD12:GFP:B0015 
pJ024mRm_AE(K) 2CC05 J23102:B0034m:RFP:B0015 
pJ024mGm_EF(K) 2CC06 J23102:B0034m:GFP:B0015 
pJ022mRm_AE(K) 2CC07 J23102:B0032m:RFP:B0015 
pJ022mGm_EF(K) 2CC08 J23102:B0032m:GFP:B0015 
pJ14B2Rm_AE(K) 2CC09 J23114:BCD2:RFP:B0015 
pJ14B2Gm_EF(K) 2CC10 J23114:BCD2:GFP:B0015 
pJ14B12Rm_AE(K) 2CC11 J23114:BCD12:RFP:B0015 
pJ14B12Gm_EF(K) 2CC12 J23114:BCD12:GFP:B0015 
pJ144mRm_AE(K) 2CC13 J23114:B0034m:RFP:B0015 
pJ144mGm_EF(K) 2CC14 J23114:B0034m:GFP:B0015 
pJ142mRm_AE(K) 2CC15 J23114:B0032m:RFP:B0015 
pJ142mGm_EF(K) 2CC16 J23114:B0032m:GFP:B0015 
pJ02B2Rm:Gm_AF(A) 2CC18 J02B2Rm:J02B2Gm 
pJ02B12Rm:Gm_AF(A) 2CC19 J02B12Rm:J02B12Gm 
pJ024mRm:Gm_AF(A) 2CC20 J024mRm:J024mGm 
pJ022mRm:Gm_AF(A) 2CC21 J022mRm:J022mGm 
pJ14B2Rm:Gm_AF(A) 2CC22 J14B2Rm:J14B2Gm 
pJ14B12Rm:Gm_AF(A) 2CC23 J14B12Rm:J14B12Gm 
pJ144mRm:Gm_AF(A) 2CC24 J144mRm:J144mGm 
pJ142mRm:Gm_AF(A) 2CC25 J142mRm:J142mGm 
pJ02B2Gm_AE(K) 2CC38 J23102:BCD2:GFP:B0015 
pJ02B2Rm_EF(K) 2CC39 J23102:BCD2:RFP:B0015 
pJ024mGm_AE(K) 2CC40 J23102:B0034m:GFP:B0015 
pJ024mRm_EF(K) 2CC41 J23102:B0034m:RFP:B0015 
pJ02B2Gm:Rm_AF(A) 2CC42 pJ02B2Gm:pJ02B2Rm 
pJ024mGm:Rm_AF(A) 2CC43 pJ024mGm:pJ024mGm 
pJ02B2B_AE(K) 2CC44 J23102:BCD2:eBFP2:B0015 
pJ02B2B_EF(K) 2CC45 J23102:BCD2:eBFP2:B0015 
pJ02B2Rm:B_AF(A) 2CC46 pJ02B2Rm:pJ02B2B 
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Plasmid ID 2CC# Construct 
pJ02B2Gm:B_AF(A) 2CC47 pJ02B2Gm:pJ02B2B 
pJ02B2B:Gm_AF(A) 2CC48 pJ02B2B:pJ02B2Gm 
pJ02B2B:Rm_AF(A) 2CC49 pJ02B2B:pJ02B2Rm 
pJ02B2Rm_AE(A) 2CC01(A) J23102:BCD2:RFP:B0015 
pJ02B2Gm_EF(A) 2CC02(A) J23102:BCD2:GFP:B0015 
pJ02B12Rm_AE(A) 2CC03(A) J23102:BCD12:RFP:B0015 
pJ02B12Gm_EF(A) 2CC04(A) J23102:BCD12:GFP:B0015 
pJ024m1Rm_AE(A) 2CC05(A) J23102:B0034m:RFP:B0015 
pJ024m1Gm_EF(A) 2CC06(A) J23102:B0034m:GFP:B0015 
pJ022mRm_AE(A) 2CC07(A) J23102:B0032m:RFP:B0015 
pJ022mGm_EF(A) 2CC08(A) J23102:B0032m:GFP:B0015 
pJ14B2Rm_AE(A) 2CC09(A) J23114:BCD2:RFP:B0015 
pJ14B2Gm_EF(A) 2CC10(A) J23114:BCD2:GFP:B0015 
pJ14B12Rm_AE(A) 2CC11(A) J23114:BCD12:RFP:B0015 
pJ14B12Gm_EF(A) 2CC12(A) J23114:BCD12:GFP:B0015 
pJ144m1Rm_AE(A) 2CC13(A) J23114:B0034m:RFP:B0015 
pJ144m1Gm_EF(A) 2CC14(A) J23114:B0034m:GFP:B0015 
pJ142mRm_AE(A) 2CC15(A) J23114:B0032m:RFP:B0015 
pJ142mGm_EF(A) 2CC16(A) J23114:B0032m:GFP:B0015 
pJ02B2Gm_AE(A) 2CC38(A) J23102:BCD2:GFP:B0015 
pJ02B2Rm_EF(A) 2CC39(A) J23102:BCD2:RFP:B0015 
pJ024mGm_AE(A) 2CC40(A) J23102:B0034m:GFP:B0015 
pJ024mRm_EF(A) 2CC41(A) J23102:B0034m:RFP:B0015 
pJ02B2Gm:Rm_AF(K) 2CC42(K) pJ02B2Gm:pJ02B2Rm 
pJ024mGm:Rm_AF(K) 2CC43(K) pJ024mGm:pJ024mGm 
Table 2-1 Table of Two Color Control (2CC) plasmids used to develop color model. These 
plasmids can also be found online in the public Benchling directory. 
2.4.4 TASBE tools 
Flow cytometry data was converted from arbitrary units to compensated 
Molecules of Equivalent Fluorescein (MEFL) using the TASBE characterization 
method (Beal et al. 2012). An affine compensation matrix is computed from single 
color and blank controls: RFP alone (J23102:BCD2:E1010m:B0015, abbreviated 
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as pJ02B2Rm, in _AE and EF DVAs), GFP alone (J23102:BCD2:E0040m:B0015 
abbreviated as pJ02B2Gm, in _AE and EF DVAs), RFP:GFP 
(pJ02B2Rm:J02B2Gm in _AF DVAs) as well as the reciprocal GFP:RFP 
(pJ02B2Gm:J02B2Rm in _AF DVAs) together and untransformed DH5 Alpha 
Select E. coli cells (Bioline), respectively. FITC measurements (for GFP) are 
calibrated to MEFL using SpheroTech RCP-30-5-A beads (Spherotech 2001). An 
estimated mapping from RFP measured in the PE-Texas Red channel to 
equivalent FITC is computed from transformation of constitutive co-expression of 
RFP and GFP expressed together (RFP:GFP as pJ02B2Rm:J02B2Gm as _AF in 
DVA, GFP:RFP as pJ02B2Gm:J02B2Rm as _AF in DVA); RFP measurements are 
translated to MEFL by first mapping to estimated equivalent FITC. Geometric 
statistics are then computed over data in MEFL units. 
2.5 CIDAR MoClo Library preparation 
2.5.1 Glycerol storage 
All plasmids made for use in CIDAR MoClo and specifically for the published 
CIDAR MoClo Library were sequence verified and stored at -80°C as individual 
glycerol preps in 300-1mL of LB with 25% glycerol. In preparation for submitting 
the CIDAR MoClo Library to Addgene, and to provide backup stocks for internal 
use, the glycerol stocks were used to inoculate fresh plates and single colonies 
from theses plates were used to inoculate 96 well deep culture plates (1mL max 
volumes). These plates were grown overnight in 500 µL of LB with appropriate 
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antibiotic and frozen after addition of 25% glycerol, mixed by shaking at 900 rpm 
sealed with PCR sealing film.  
2.5.2 Benchling 
All plasmids described in this text can be found in public folders on the 
Benchling lab management tool at https://benchling.com/siverson/. 
2.5.3 CIDAR-ICE 
All plasmids in the CIDAR MoClo Library are made public in the CIDAR 
Inventory of Composable Elements (ICE) web based inventory (http://cidar-
ice.org). The ICE platform was initially developed by the Joint BioEnergy Institute 
(JBEI, www.jbei.org) to facilitate the sharing of DNA parts between research 
groups and facilities (Ham et al. 2012).  
2.6  Aldolase Methods 
2.6.1 Plasmid design of aldolase expression cassettes 
HRA_CD and R42A_CD were cloned as basic parts with the DVA_CD 
vector as described previously using PCR templates provided by the Tolan lab. 
Extrapolating from the RFP and GFP data presented in section 3.2.3 (Figure 3-3 
and Figure 3-4), three _AB and two _EB plasmid configurations were chosen 
which were predicted to produce similar high expression of the gene of interest 
(goi). These plasmids were chosen due to their low variability in replicates and 
similarity between green and red expression cassettes and are described in detail 
in 4.2.1 and Table 4-1 and at https://benchling.com/siverson/. Each chosen 
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combination of promoter, RBS part, vector and aldolase variant (HRA_CD or 
R42A_CD) were assembled using standard MoClo protocols as described in 
section 2.3.1.  
The HRA transcription units were designated pJ06B12HRA_AE(K), 
pJ07B2HRA_AE(K), pJ07B12HRA_AE(K), pJ02B2HRA_EF(K), 
pJ02B12HRA_EF(K) and nicknamed Tolan-1 through Tolan-5 respectively. The 
HRA transcription units were designated pJ06B12R42A_AE(K), 
pJ07B2R42A_AE(K), pJ07B12R42A_AE(K), pJ02B2R42A_EF(K), 
pJ02B12R42A_EF(K) and nicknamed Tolan-6 through Tolan-10 respectively. 
Tolan-1 and Tolan-6 differ only in by goi, and likewise for the rest of this series (2 
and 7, 3 and 8, etc.). Sequences were verified using VF2 and VR primers as 
described previously.  
Each combination of pJXBXHRA_AE and pJXBXR42A_EF were combined 
to create the dual expression cassettes expressing HRA upstream of R42A. 
Likewise, each combination of pJXBXR42A_AE and pJXBXHRA_EF were also 
created for a combined total of twelve _AF(A) duel expression plasmids 
(Figure 4-1). These plasmids are designated as follows; 
pJXBXHRA:pJXBXR42A_AF(A) where pJ6B12HRA:pJ02B2R42A_AF(A) would 
be described as Tolan-1-9 as it consists of Tolan-1 and Tolan-9 transcription units. 
These duel expression plasmids were provided to the Tolan lab for protein isolation 
and quantification. 
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Due to the nearly perfect sequence homology between HRA and R42A, 
varying only with the 5’ His tag and a single internal amino acid substitution, 
separation and quantification by antibody methods is difficult. To aid in analyzing 
the relative expression of each component of the duel expression cassettes, each 
Tolan-1 through-10 were subcloned into DVA vectors to provide Tolan-1(A), Tolan-
2(A), etc.  
Upon sequence verification, all of these plasmids were provided to the 
Tolan lab for protein isolation and quantification. 
2.6.2 Plasmid design of aldolase fluorescent protein fusion plasmids 
Concurrently, fluorescent fusion protein (FP) coding sequences were 
constructed by linking the first 36 nucleotides of each aldolase variant to the full 
CDS of E0040m (GFP) and E1010m (RFP) as shown in Figure 4-4 and annotated 
online at https://benchling.com/siverson/. These fusion protein coding sequences, 
HRA:GFP_CD, HRA:RFP_CD, R42A:GFP_CD, and R42A:RFP_CD were used to 
assemble the fluorescent of expression plasmids described in 2.6.1 in order to use 
fluorescence as a proxy for aldolase protein expression.  
2.6.3 Fluorescence measurement of fusion proteins 
Fluorescence expression of aldolase:FP fusion expression plasmids was 
recorded using a Tecan plate reader with Magellen software as described in 2.4.2.  
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2.6.4 Protein expression analysis 
Western blots using α-aldolase and α-His antibodies were performed on 
lysates from each of these dual expression clones and compared to isolated 
protein standards for HRA and R42A (Tolan lab).  
2.7 Inducible pH sensor methods 
2.7.1 Bacterial strains, growth conditions 
Initial experiments were done using DH5α cells (Bioline, Alpha Select Gold 
Efficiency E. coli). Later experiments used TOP10 cells as noted in the text. 
Plasmids were built using MoClo as described previously and are described in 
Chapter 5. Cultures used for single time point pH assays were grown under 
standard conditions in 14mm plastic culture tubes, 3 mL LB with appropriate 
antibiotic, 37°C 300 rpm, and pH was tested at defined time points. 
Final experiments and logic gate tests were grown as described with the 
addition of continuous monitoring. Briefly, the pH probe was placed in the culture 
(1.5 mL) while shaking, sealed with parafilm, with wires placed carefully along the 
seam of the incubator to connect to the Raspberry Pi placed nearby. pH 
measurement method are described below. Culture for inducible YFP expression 
with the pOR30 plasmid was grown overnight under standard conditions. For YFP 
induction, 100 µL of overnight culture was aliquoted to a well in a 96 well plate 
along with control wells containing 100 µL of overnight growth of appropriate 
cultures and 100 µL of fresh LB and sealed with breathable film. Upon induction 
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as described below, 100 µL of inducer diluted in LB was injected into the sealed 
well. The plate was incubated at 37°C, 900 rpm for 2 hours.  
2.7.2 Plasmid designs 
DVK_AE was used as a control for LacZ expression. pR10LacZDV_AE was 
built to mimic DVK with modular parts and inducible Lac promoter (BBa_R0010). 
pBADLacZDV:J024mC80_AF contains two transcription units which express LacZ 
and AraC to allow for inducible expression with arabinose. 
pTetLacZDV:J024mC40_AF was built to constitutively express the tetracycline 
repressor, TetR derived from the BioBrick part C0040, to allow for induction of 
LacZ expression via the pTet promoter and the inducer molecule anhydrous 
tetracycline (aTc).  
pOR30 was a gift from the Voigt lab at the Massachusetts Institute of 
Technology (MIT). This plasmid expresses YFP under the control of the pLas 
promoter to enable inducible expression with N-3-oxo-dodecanoyl-L-Homoserine 
lactone (HSL) (Cayman Chemicals, Cat #10007895, CAS 168982-69-2).  
2.7.3 Evaluation of pOR30 
Induction curves were performed with concentrations of HSL ranging from 
1 mM to 100 mM over a period of two hours with a 1:2 dilution of overnight culture 
and fresh LB. A final concentration of 10 mM was determined to be optimal with a 
1-2 hour incubation time at 37°C, 900 rpm. 
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2.7.4 pH measurements with Raspberry Pi 
A Raspberry Pi processor was programmed language to interpret the signal 
from an Atlas Scientific pH probe (Cat #ENV-40-pH) with an Ezo pH Circuit (Cat 
#EZO-pH)after calibration with standard pH calibration solutions (pH 4, 7, and 10) 
(Cat #KIT-101P). PuTTY terminal (www.putty.org) was used to control the 
Raspberry Pi interface.  
2.7.5 pH mediated induction of YFP 
Upon sensing a target pH value the Raspberry Pi connected to the pH probe 
was programmed to submit a Twitter post to the @CIDARlab Twitter feed using 
the Twitter API. This tweet functioned as the input signal for a second Raspberry 
Pi connected to a servo motor and a 3D printed syringe pump calibrated to 
dispense 100 µL (+/- 3 µL) through 7/32” medical grade tubing and 14G needle 
point. Upon detecting the Tweet from Raspberry Pi 1, Raspberry Pi 2 activated the 
servo motor to inject 100 µL of 20 µM homoserine lactone in LB into a sealed well 
of a 96 well plate to induce the expression of YFP in cells carrying the pOR30 
plasmid (Voigt Lab, MIT).  
2.8 CNC milling and 3D printing 
All 3D printing, done with an Ultimaker 2 printer and stock materials, and 
CNC milling using an Othermill CNC mill and polycarbonate (PCA) stock, was 
performed by Ryan Silva, at Boston University. An open source .stl design for a 
syringe pump was modified for use in Chapter 5. The original designs were 
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developed at MIT (Wijnen et al. 2014) and files can be found online 
(http://matter.media.mit.edu/tools/details/3d-printed-syringe-pump). 
A 5x5 array of wells, styled after a 96-well plate, was CNC milled in PCA 
designed to fit into the D8-H12 region of a 3D printed 96-well plate frame. The 5x5 
well array was sterilized with alcohol and bleach before inoculation of cultures in 
LB with appropriate antibiotic. The array was sealed with breathable culture film, 
placed inside the 96-well plate frame and incubated at 37°C, 900 RPM in a shaking 
plate incubator. 
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3 CHAPTER 3 IMPROVED MULTIPART, MODULAR, DNA ASSEMBLY 
(CIDAR MOCLO) AND NEW E. COLI COMMON PART LIBRARY 
3.1 Introduction 
MoClo, which was developed by Weber et. al in 2011, relies upon Type IIS 
restriction enzymes (BbsI and BsaI). Each recognize a 6 base pair non-palindromic 
sequence and cut at a specified distance from that recognition sequence resulting 
in overhanging 4 bp fusion sites (Figure 3-1). Due to the nature of these cutting 
patterns, the 4 bp fusion sites can be any four nucleotides and can thus be defined 
as standard sites in this assembly method. For example, CDS parts are flanked 
with ‘-AATG-’ at the 5’ end and ‘-AGGT-’ on the 3’ end making all parts 
interchangeable. The restriction recognition sites are placed and oriented such that 
the digest product ends in these specific four base pair overhangs and no longer 
contains the restriction enzyme recognition sequence. Once ligated it cannot be 
recut allowing for a hierarchical multipart assembly.  
The original MoClo protocol allowed for the reliable assembly of up to six 
parts in a five hour digestion-ligation reaction with large reagent volumes and 
rotating use of three antibiotics and two color selection modules. Although this 
provided a substantial improvement in modularity compared to Golden Gate, the 
reaction conditions were still time and cost-prohibitive for most applications. Here 
we introduce a modified protocol (Table A-2) that, while maintaining the same 
capacity for assembling multiple modules and a >95% cloning efficiency, also 
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reduces reaction time from five hours to 90 minutes and lowers reaction costs by 
85% while simplifying the hierarchical assembly standard. 
Two variations of the CIDAR MoClo system are described in this chapter. 
The first, the 3 antibiotic selection (3Ab MoClo) system was initially used in the 
CIDAR lab to build many of the plasmids discussed throughout this chapter. In 
order to streamline and optimize the CIDAR MoClo standard, this system was later 
converted to a two antibiotic selection system which and published as the CIDAR 
MoClo assembly standard and library.  
3.2 Results 
3.2.1 3Ab MoClo parts collection, 3 antibiotic assembly standard 
To create destination vectors, pSB1C3, pSB1K2 and pSB1A2 BioBrick 
vectors were modified by inserting a LacZ alpha fragment expression cassette 
flanked with BbsI and BsaI recognition sequences and MoClo fusion sites into a 
SpeI site. Flanking sequences are shown in Table A-5. Adapted from the original 
published MoClo protocols, fusion sites were chosen as shown in Figure 3-1. An 
array of commonly used BioBrick parts were adapted for use in a MoClo standard 
by cloning into the pSB1C3 derived DVL0 vectors.  
The 3Ab MoClo parts collection and standard used an alternating series of 
vectors (Figure 3-1). Basic parts were provided in a Destination Vector Level 0 
(DVL0) derived from BBa_pSB1A2, with BsaI sites flanking the part and fusion 
sites. These basic parts combine to create a simple transcription unit (TU) 
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consisting of promoter:RBS:CDS:terminator in a Level 1 kanamycin vector (DVL1) 
derived from BBa_pSB1K3 with BbsI sites flanking the newly constructed TU. 
These units can be further combined into multi-TU devices in the same manner 
using a Level 2 ampicillin vector (DVL2).  
We created a standard four-part structure that allows users to easily 
assemble a genetic device consisting of a promoter, RBS, CDS, and terminator. 
This basic format provides a solid foundation for high throughput assembly while 
remaining adaptable to addition of new parts (i.e. new fusion site combinations) 
and part types. This 3Ab system (Haddock et al. 2015) was later adapted to 
become the CIDAR MoClo assembly standard.  
 48 
 
 
Figure 3-1 Initial three antibiotic selection assembly standard. The initial CIDAR MoClo part 
collection used a three-tier antibiotic resistance standard with basic parts (Level 0) cloned into 
DVL0 chloramphenicol resistance plasmids, transcription units (Level 1) in DVL1 kanamycin 
resistant plasmids and devices (Level 2) in DVL2 ampicillin resistant plasmids. 
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3.2.2 Optimized MoClo protocols  
The originally published MoClo protocols used 40 fmol of each DNA part 
and a five hour incubation at 37°C with final 5’ 50°C and 10’ 80°C steps. In the 
largest assembly published in this study the authors used a cycling protocol to 
increase efficiency which consisted of 45 cycles of alternating 2’ 37°C and 5’ 16°C 
with the same final steps. Both of these protocols provided high efficiency cloning 
and both required approximately 5.5 hours of incubations (Weber et al. 2011).  
In order to optimize the MoClo protocols both time- and cost-sensitive 
parameters were evaluated. Identical reactions were performed (Level 1, 
fluorescent expression transcription units) using a cycling MoClo protocol with 15, 
20, 25, 30 or 40 cycles (37°C 1.5 or 3’, 16°C 3 or 5’), followed by 50°C for 5’ and 
80°C for 10’ then held at 4°C or -20°C until transformed in either Bioline Alpha Gold 
Select DH5α cells or the same strain prepped with the Zymo chemically competent 
cell preparation kit.  
BsaI (NEB Cat #R0535S) and BbsI (NEB Cat #R0539S) were used in all 
assemblies as appropriate. NEB T4 Ligase (Cat #M0202L) and Promega T4 
Ligase (Cat # M1794) were compared, each tested with NEB T4 Ligase Buffer (Cat 
#B0216L) and Promega T4 Ligase Buffer (Cat #C1263). Number of cycles, length 
of steps, reaction volume and reagent concentration were varied.  
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Figure 3-2 Optimization of Weber protocol to develop CIDAR MoClo protocols. Optimization 
of protocols decreased cost from approximately $10 to $1.50 per reaction, reduced time from 5 
hours to less than 90 minutes and maintained >95% cloning efficiency. Volumes, concentrations, 
cycling times, and number of cycles were each evaluated.  
 
3.2.3 Two color controls, color model, and part characterization 
We used the library and protocols to construct the 2 Color Controls (2CC) 
series of plasmids described in 2.4.3. FACS analysis was run as described in 2.4.1 
and the data was used to define the ideal color controls for future FACS 
experiments. Additionally, these plasmids were used to create a color model by 
normalizing flow cytometry fluorescence data to SpheroTech RCP-30-5-A beads 
as a fluorescein standard (Figure 3-3a). This color model allows us to directly 
correlate RFP and GFP expression as molecules of equivalent fluorescein (MEFL) 
counts rather than arbitrary units (Figure 3-3b). 
This color model was validated by comparing MEFL counts of 28 pairs of 
plasmids with various promoter, RBS, and fusion site combinations (mean square 
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error = 1.80 fold) in which each pair differed only in the coding sequence 
(E0040m_CD GFP or E1010m_CD RFP) (Figure 3-3c).  
 
Figure 3-3 Molecules of Equivalent Fluorescein (MEFL) normalization of flow cytometry data. 
SpheroTech 8-peak beads provide a basis for normalizing across fluorescence channels using a 
physical standard. (a) Peaks visible with selected laser voltages and filters for green fluorescent 
protein (left) and red fluorescent protein (right). RFP measurements are translated to MEFL by first 
mapping to estimated equivalent FITC. Geometric statistics are then computed over data in MEFL 
units. (c) To validate MEFL normalization, 28 pairs of transcription units were compared in which 
only the CDS varied (RFP on the y-axis verses GFP counterparts on the x-axis). An approximate 
1:1 ratio is observed with a mean square error of 1.80 fold. 
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An array of GFP reporters composed of 16 constitutive promoters (J23100 
Anderson series) and 6 RBS type parts (3 Weiss RBS, 3 BCD) constructed to 
characterize the transcription and translation elements to explore the potential for 
rational design using these parts. The resulting 96 iterations of a simple GFP 
expression plasmid in a DVK_AE vector were analyzed using flow cytometry 
(Figure 3-4a,b). Two-way ANOVA analysis identified 36.3% of expression 
variation as being due to the promoter, 43.9% due to RBS part, and 19.3% due to 
the interaction of the two factors.  
 
Figure 3-4 Array of expression vectors constructed from a collection of 16 consitutive 
promoters and 6 RBS type parts (3 Weiss RBS, 3 BCDs). (a) Construction of arrays with multiple 
promoters and RBS parts, one CDS part, one terminator, vector. (b) pJXGm_AE(K) expression 
array consists of 16 promoters and six RBS parts. TUs containing RBS parts B0034m, BCD2, and 
BCD12 and promoters J23100, J23101, J23102, and J23118 have the highest GFP fluorescence. 
(c) Subset of the contexts demonstrated in (b) with RFP in place of the GFP CDS. (d) Subset of 
the contexts demonstrated in (b) with RFP in place of GFP and flanked with _EF fusion sites in 
place of _AE. In both c and d a similar expression pattern can be seen with B0034m, BCD2, and 
BCD12, J23100, and J23102 demonstrating high levels of expression. Max and min for each array 
(color coded) are noted in MEFL units.    
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To compare the expression patterns with a different CDS, a subset of this 
array was made using RFP in place of GFP (Figure 3-4a,c). The overall pattern 
appears similar, though the range of expression is approximately 2-fold larger than 
with the corresponding GFP array (max MEFL value of 50902 as compared to 
22693). A third small array was analyzed using the RFP transcription units in a 
DVK_EF vector as compared to the DVK_AE vector in Figure 3-4 parts b and c. 
This subset shows a much smaller range and lower max signal compared to the 
RFP _AE array in part c offering the first indication that the flanking fusion sites 
influence expression.  
 
Figure 3-5 Pairwise comparisons of context effects. (a) Single TU expression compared to the 
same TU when expressed in the same plasmid with another TU. Expression of a single TU is 
consistent when assembled into a larger device. (b) Changing vector from DVA to DVK shows a 
high level of variability, suggesting all expression tuning should be done in the same vector. (c) 
Changing the 4 base pair fusion sites flanking a given TU influences expression likely due to the 
proximity of the 5’ fusion site to the minimal 35 bp promoter used in this study.  
To further assess the capability for rational design under commonly varied 
genetic contexts, other pairwise comparisons were performed to evaluate the 
effects of gene order, variation in vector, and use of specific fusion sites flanking 
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the transcription unit. Expression of a single TU was shown to remain constant 
when expressed in a plasmid with a second TU up- or downstream (Figure 3-5a) 
(mean sq. error = 1.53 fold). Changing the vector from DVA to DVK while 
maintaining the same transcription unit showed a higher variability yet retained a 
nearly linear relationship (mean sq. error = 2.61 fold) (Figure 3-5b).  
Modifying the four base fusion sites did have an effect on expression 
(p<0.001) in a paired analysis in the _EF transcription unit when compared to the 
_AE paired clone (mean sq. error = 2.02 fold) (Figure 3-5c). This difference may 
be due to the proximity of the 5’ fusion site to the simple promoter. Including an 
insulator upstream of the promoter sequences may mitigate this effect. 
In order to select the constitutive promoters to be included in the CIDAR 
MoClo Library, the data from Figure 3-4b was graphed as seen in Figure 3-6, and 
Figure 3-7. Six constitutive promoters were chosen which would provide a full 
range of expression capabilities (as defined by GFP expression ranging from 102 
– 105 MEFLs) when paired with these six RBS parts, also included in the library. 
The MEFL data used to create Figure 3-3c, Figure 3-4, Figure 3-5, Figure 3-6, 
and Figure 3-7 can be found in Appendix A along with a concise histogram of the 
GFP expression of promoter:RBS combinations included in the library 
(Figure A-2). 
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Figure 3-6 GFP expression under the control of variable promoters and RBS. Data here sorted 
by promoter to guide selection of promoter parts in future constructs. Same data as presented in 
Figure 3-4b. Subset of data for parts included in the CIDAR Library are in Appendix A.  
 
 
Figure 3-7 GFP expression under the control of variable promoters and RBS. Data here sorted 
by RBS to guide selection of RBS parts in future constructs. Same data as presented in 
Figure 3-4b. Subset of data for parts included in the CIDAR Library are in Appendix A. 
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3.2.4 Publicly available CIDAR MoClo E. coli part library and assembly standard 
Most of the parts contained in the CIDAR E. coli MoClo Library are derived 
from the BioBricks Registry (http://parts.igem.org/) and were selected for their 
functional reliability and utility in synthetic biological designs (Table A-7). To 
enable rational design, three of the basic parts were selected from the BIOFAB 
collection of BCD translational elements which have been shown to enable more 
rational design in terms of protein expression (Mutalik et al. 2013a). These BCD 
parts contain a leader peptide followed by a secondary RBS in order to physically 
separate transcriptional and translational regulation. 
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Figure 3-8 CIDAR MoClo Library, part and vector structure. The CIDAR MoClo Library provided 
in a 96-well plate (Addgene, #1000000059). CIDAR MoClo assembly standard is based on four 
part transcription units comprised of a promoter, ribosome binding site, coding sequence and 
terminator assembled into a DVK (Kanamycin-resistance destination vector). Destination vectors 
alternate antibiotic resistance at each level and use lacZα blue-white selection. 
Destination vectors are included in the library to allow for simple cloning of 
new parts with any of the standard fusion site pairs. From the initial 3Ab assembly 
standard, the DVL0 vectors have been removed from the rotation and replaced 
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with the DVA vector (Figure 3-8). DVA is derived from DVL2 which was a modified 
pSB1A2 carrying an illegal site in the bla ampicillin antibiotic resistance gene. This 
illegal site was repaired with a synonymous single codon mutation to produce DVA. 
All basic parts are provided in DVA vectors. These are then assembled into 
transcription units in DVK vectors (previously designated as DVL1) (Figure 3-9). 
The circuit or device level of assembly combines two or more TUs into a DVA 
vector. Further hierarchical assembly is possible by continuing the DVA – DVK 
rotation.  
In addition to the parts and vectors, a set of fluorescent expression plasmids 
is also included to be used as standards with the TASBE flow cytometry analysis 
tools (Beal et al. 2012) (Table A-7). Sequence and part information for all plasmids 
is available in the CIDAR Inventory of Composible Elements (ICE) registry 
(http://cidar-ice.org). Other plasmids for use in E. coli not included in this library 
are available upon request. 
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Figure 3-9 CIDAR MoClo Assembly Standard. Basic parts shown with green backbones are 
prepared in DVAs with part specific fusion sites, indicated with single capital letters. The 3’ fusion 
site of the upstream part must match the 5’ fusion site of the following part in order to be correctly 
assembled. Digesting parts and a DVK with the BsaI and simultaneous ligation with T4 DNA ligase 
results in a transcription unit (TU) shown here with the orange backbone. Multiple TUs can be 
combined into a complex device using BbsI in place of BsaI with the appropriate DVA. 
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3.2.5 Multiplex Modular Cloning (MMC) 
As a MoClo reaction is dependent upon equimolar ratios of each part type, 
a logical advance on the methodology is to multiplex reactions by adding various 
plasmids of the same part type at 1/n the concentration of each other part type 
where n equals the total number of iterations. Multiplex MoClo (MMC) allows for 
an expanded utility including simultaneously screening a large number of iterations 
in parallel while retaining >95% cloning efficiency. Examples of this methodology 
include screening of variant sequences, or modulating expression levels of a single 
transcription unit by multiplexing the promoter and/or RBS part (Figure 3-10). 
Multiplex MoClo reactions have been performed using up to 6 different part 
types with as many as three part types multiplexed without decreasing efficiency. 
Library creation using multiplex MoClo could facilitate the development of fusion 
proteins with additional fusion sites used to build a CDS part from intermediates. 
The DVL0_CX, DVL0_CY, DVL0_XY, DVL0_XD and DVL0_YD vectors were 
created for this purpose and used to assemble fusion proteins comprised of three 
domains (estrogen receptor - cre recombinase - estrogen receptor, in one 
example).   
By creating a library of _CX protein coding sequences and a _XD encoded 
tag (His-tag for example) a library of tagged protein sequences can be created in 
a single assembly step. This same approach could be applied to protein 
engineering to determine the optimal residues at which to create a fusion or to 
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experiment with linker designs using the _XY part type. Mass production of 
fluorescent reporters could be assembled with the same methods.  
 
Figure 3-10 Multiplex MoClo. The modular format of MoClo allows for simple multiplexing of one 
or more part types by the addition of 1/n of the molar concentration of each part where n = the total 
number of parts of that type. (a) Basic structure of Multiplexed MoClo (MMC). (b) Assembly of a 5 
x 5 multiplex reaction in which both the promoter and RBS type part are multiplexed as seen in the 
red coded section of (c). (c) MMC of five promoters with BCD2, GFP, a standard terminator and 
DVK_AE (pJXB2Gm) provides five distinct populations of fluorescent cells. Likewise, multiplexing 
both the promoter and RBS type part results in more populations than can be accurately identified 
from fluorescence expresssion alone (pJXRBSRm).  
One of the most powerful uses of multiplex MoClo may be found in the form 
of expression tuning of complex devices. By multiplexing the promoter and RBS 
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parts of one or more TU, then using the mixed population of all TUs assembled in 
those reactions to assemble a multi-TU device, a vast array of iterative designs 
can be assembled in a single tube and screened for the desired function. When 
combined with fluorescent output signals, this expression tuning can be used in 
conjunction with fluorescence activated cell sorting to measure and isolate only 
those clones which demonstrate the desired behavior. 
3.2.6 Insulating recombinase sites within BiCistronic Designs (BCDs) 
In the interest of developing cre recombinase based memory devices, 
preliminary investigations into the ability to use BCD parts as insulators was 
investigated. A commonly used recombinase, cre and its cognate recognition 
sequence, LoxP, are well studied as genome modifying tools in transgenic mouse 
research and recombinase memory devices in synthetic biology (Orban et al. 1992, 
Friedland et al. 2009). The placement of LoxP, the cre recognition sequence, 
between promoter and RBS parts proved problematic in early designs with 
BioBrick assembly, ameliorating fluorescence expression (data not shown). The 
LoxP sequence (36 nt) was placed in frame in the short encoded peptide sequence 
of BCD parts where it would be translated, disrupting any secondary structure 
which might otherwise influence expression. New RBS type parts were made 
(BCD2lox_BC, BCD12lox_BC, etc.) which included a potentially insulated LoxP 
site (Figure 3-11).  
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An accurate measure of insulation would have required a related construct 
containing LoxP between the promoter and CDS without the use of an insulator. 
However, these designs would also invariably offer other explanations for 
sequence variance such as the sequence context surrounding the promoter or 5’ 
region of the gene. In order to accurately measure insulating effect, a wide variety 
of constructs would need to be tested to identify factors influencing expression, 
making true comparison of insulation effect on a small scale difficult.  
A small preliminary experiment was performed to assess whether 
transcription units carrying an embedded LoxP sequence expressed a fluorescent 
goi similarly to the counterpart transcription unit lacking the LoxP sequence. In five 
of the eight instances tested, transcription units with embedded LoxP sequences 
showed expression similar to that of counterpart TUs lacking LoxP. 
While this data is not conclusive, it does suggest that embedding repetitive 
or A/T rich sequences within the translated portion of the BCD may prevent 
secondary structure and minimize detrimental effects of the given sequence on 
protein expression. Further experimentation is needed to determine the full 
potential of this technique.  
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Figure 3-11 BCD parts as insulators. Devices like those shown in the top left are difficult to design 
rationally due to the inclusion of hairpin-forming recognition sequences in the transcription and 
translation control regions. LoxP was placed inside the peptide coding sequence of the BCD part 
to insulate and disrupt the hairpin structure as illustrated (middle left). (right)  In five of the eight 
instances tested, inclusion of the LoxP sequence within the BCD part resulted in similar levels of 
fluorescent protein expression similar to that of counterpart TUs lacking LoxP.  
3.2.7 CIDAR Inventory of Composable Elements (CIDAR ICE) 
The Inventory of Composable Elements (ICE) is an open source registry 
designed to assist in management of DNA part and strain information (Ham et al. 
2012). ICE was built to facilitate the creation of a web of registries, with support for 
distributed interconnected use. Currently, ICE registries have been implemented 
at multiple research facilities including Stanford University, University of California 
Berkeley, Joint Genome Institute (JGI), Harvard Medical School, Synberc (NSF 
funded synthetic biology consortium), and now Boston University (Paige 2014).  
CIDAR-ICE is a publicly available database displaying sequence and part 
information for the CIDAR MoClo Library (https://cidar-ice.org) (Figure 3-12).  
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Figure 3-12 CIDAR-ICE, publicly available parts registry. Part of the Web of Registries (JBEI-
ICE), the CIDAR-ICE registry can be found at http://cidar-ice.org. Top left: Sign in page. Top right: 
Plasmid map example. Bottom: Home screen view of plasmids available.  
 
3.3 Discussion 
3.3.1 CIDAR MoClo E. coli part library 
Four MoClo part libraries were previously available providing reusable parts 
and vectors for plant transformation constructs (Addgene, #1000000047), general 
eukaryotic multigene construct assembly (Addgene, #1000000044), mammals 
(mMoClo, (Duportet et al. 2014)) and yeast (Addgene, #1000000061). Recent 
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publications have also detailed the development of yeast Golden Gate (yGG) and 
BASIC assembly methods both of which employ a similar digestion and ligation 
reaction, though neither offer a part library to accompany the methods. To address 
the lack of publically available standardize parts for bacterial systems, we have 
constructed and characterized a library of commonly used genetic parts and the 
necessary vectors in MoClo format for use in E. coli (Addgene, #1000000059) 
(Figure 3-8 and Table A-7).  
The CIDAR MoClo part library is the first Type-IIS compatible modular part 
library available for use in bacteria.  It has already been employed by four other 
research labs by directly sharing the part library. Additionally, it is available publicly 
through Addgene along with other MoClo libraries enhancing the universality of 
this assembly standard. 
Though the chart shown in Figure 1-1 shows only sparse adoption of the 
MoClo methodology, this survey was done prior to the availability of any of these 
part libraries. With MoClo assembly methods and libraries more available and 
adapted for use in a wide variety of organisms, it is to be expected that adoption 
of MoClo methods will increase rapidly. Efforts to educate and promote the use of 
these systems would help to increase their adoption rates.  
One approach to increasing adoption of the MoClo assembly methods is to 
incorporate these methods into high school and university level biology labs, 
familiarizing more students with Type IIS assembly methods at an early point in 
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their research careers. MoClo is an ideal teaching tool for demonstrating the 
concepts of synthetic biology and modular engineering. As such, Appendix C in 
this work includes basic teaching lab materials which cover the assembly of a 
single transcription unit, multiplex MoClo assembly and analysis, and the 
construction of a two color fluorescent plasmid.  
3.3.2 MoClo assembly standard variations 
Each library uses a variant of the same format to adapt to the target 
organisms. The original Weber protocol uses five basic parts (promoter, RBS, 
signal peptide, CDS, and terminator) and a series of vectors. The CIDAR MoClo 
system was adapted from this standard with a four part format and a series of 
destination vectors. The yeast system, MoClo-YTK, uses eight primary part types 
with individual parts making up the origin and marker portion of the backbone (Lee 
et al. 2015).  The mammalian MoClo (mMoClo) standard uses six basic parts 
(insulators, promoters, 5’UTR, genes, 3’UTR, and polyA) to assemble transcription 
units or gene trap plasmids containing att sites (Duportet et al. 2014). 
Two fusion sites flank transcription units and in most MoClo formats end 
linker parts are used to enhance modularity (Weber et al. 2011). The Weber MoClo 
format rotates three antibiotics and two color selection (LacZ and CRed) whereas 
the CIDAR MoClo standard simplifies this rotation to two antibiotics and one color 
selction (LacZ). Between the Weber and CIDAR assembly standards, the _AB 
promoters and all RBS part types (_BC) are directly compatible.  
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 Weber CIDAR Plant mMoClo MoClo-YTK 
# of part types 4-6 4-6 5-8 6 8-10 
Linkers yes no yes yes yes1 
Enzymes BsaI, BpiI BsaI, BbsI BsaI, BpiI BsaI, BpiI BsaI, BsmBI 
Library #1000000044 #1000000059 #1000000047 Submitted #1000000061 
Part Fusion Sites GGAG GGAG2 GGAG GGAG CCCT 
 TACT TACT TACT TACT AACG 
 AATG AATG3 CCAT AATG TATG 
 AGGT AGGT AATG AGGT TTCT 
 GCTT GCTT4 AGGT GCTT ATCC 
 CGCT  TTCG CAAC TGGC 
   GCTT CGCT GCTG 
   GGTA  TACA 
   CGCT  GAGT 
     CCGA 
     CAAT 
     CCCT 
      
1 Linkers are termed "connectors" and flank every TU. 
2 Promoters may contain one of the following 5' fusion sites (GGAG, GCTT, CGCT, TGCC) 
3 Fusion proteins can be assembled with the addition of X (CGTT) and Y (TGTG) fusion sites. 
4 Terminators may contain one of the following 5' fusion sites (GCTT, CGCT, TGCC, ACTA)  
Table 3-1 Comparison of published MoClo standards. Though four of the published standards 
use many of the same fusion sites (highlighted), the part type associated with those sites varies 
making many of these parts incompatible.  
3.3.3 MoClo & CIDAR Workflow 
To better enable a specify-design-build-test-share workflow, the CIDAR 
workflow includes tools for each stage as described in Figure 3-13. All of these 
tools are open source and publicly available to facilitate the adoption of this 
workflow by other researchers.  
 69 
 
 
Figure 3-13 CIDAR Workflow: Specification, design, build, test, share. In pursuit of automation, 
the CIDAR lab has developed a collection of tools. These allow for the specification of genetic 
circuits in human-readable computer language, automate assembly planning, provide libraries of 
DNA parts, analyze fluorescence data in MEFL units, and release all DNA parts and data publicly 
through the ICE database and other resources. 
Eugene is an ecosystem of human-readable languages for synthetic biology 
which facilitates the specification of biological devices (Bilitchenko et al. 2011, 
Oberortner et al. 2014, Oberortner and Densmore 2015). A methodology agnostic 
DNA assembly planner, Raven, provides human-readable and machine-
executable instructions for constructing complex DNA devices with Golden Gate, 
MoClo, Gibson, and BioBricks formats (Appleton et al. 2014). The CIDAR MoClo 
Library is part of the Hummingbird project, a collection composed of this and other 
MoClo libraries currently in development. The TASBE tools for normalizing 
fluorescence enable the comparison of experimental data between experiments 
and researchers (Beal et al. 2012).  
 70 
 
3.3.4 Troubleshooting and known error modes 
In developing the CIDAR MoClo Library, alternative formats and fusion sites 
were attempted with varying degrees of success. Table 3-2 describes known 
failure modes.   
In particular, a series of fusion sites were designed to enable multi-cistronic 
assembly in the form of promoter:rbs:cds:rbs:cds: terminator and 
promoter:rbs:cds:rbs:cds:rbs:cds:terminator. Previous experiments had shown 6-
part assembly to maintain high efficiency, however, these bicistronic designs were 
unsuccessful, apparently due to the choice of fusion site. In order to continue the 
practice of containing the “ATG” start site within the 5’ CDS fusion site, the C1 and 
C2 fusion sites were designated as GATG and TATG, respectively. All attempts to 
build with these parts failed, providing few white colonies all of which were 
sequenced as artifacts. These artifacts were predominately with respect to the 
5’CDS fusion sites where the _C1D1 CDS part would fuse to the _BC part rather 
than the _DC1 part, skipping the first transcription unit and other similar incorrect 
assemblies.  
This series of experiments indicated the need for greater variance in the 
fusion site sequence in a given MoClo reaction. In general, the fusion sites used 
in the CIDAR MoClo assembly standard will differ in at least 2 of the 4 base pair 
positions with respect to all other fusion sites in a given reaction.  
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Failed Assembly Strategy Name Explanation 
 
 
Multicistronic 
design 
 
C (AATG) and C1 (GATG) are too 
similar, varying by only 1 bp and allow 
for mismatch ligations. The 
A:B:C1:D1:E transcription unit was the 
most common result. Use of different 
fusion sites should enable this design. 
 
 
 
 
Palindromic 
fusion sites 
 
Palindromic fusion sites result in 
overhangs which are able to fuse to 
inverted copies of the same part rather 
than the intended downstream part, 
inhibiting correct assembly.  
 
 
 
Illegal sites 
 
Illegal sites in parts or vectors 
decrease the efficiency of a given 
reaction. The ad-hoc ‘fusion site’ made 
by an illegal restriction site may be 
palindromic, a reverse compliment of 
existing sites, or too similar to existing 
sites to allow for optimal conditions. 
Illegal sites are particularly problematic 
in Multiplex reactions when one or 
more individual parts of a multiplexed 
part type contains an illegal site.  
 
  
Reverse 
compliment 
of existing 
fusion site 
 
Fusion sites which are the reverse 
complement of an existing fusion site 
create a backward assembly step. In 
the case demonstrated here, with one 
part flanked by reverse compliment 
sequences, this creates an artifact 
whereby repeated RBS parts could 
assemble in a chainlink fashion. 
 
Table 3-2 Known failure modes. Choice of fusion sites is key for efficient and accurate MoClo 
assembly. Greater than 1 bp variance is required between sites in a given reaction. 
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3.3.5 Rational design and expression prediction with CIDAR MoClo 
Using the MEFL normalization method, plasmids made with the CIDAR 
MoClo part library have a rational expression capability with a mean square error 
of less than 2-fold. A given genetic context will express the same physical amount 
of protein regardless of the coding sequence. The BCDs in particular enable this 
rational design by reducing variation in expression due to an interaction between 
the transcription and translation elements.  
We hypothesized that the GFP and RFP data described above could be 
used to predict protein expression of a given context with any gene of interest. To 
evaluate this hypothesis, CIDAR MoClo was used to predict and build an equimolar 
dual expression plasmid, described in Chapter 4. Of the twelve candidate plasmids 
evaluated, four provided near-equal expression of two variants of a rabbit aldolase 
protein, one of which contains a 5’ His-tag. Of these, the highest co-expression 
plasmid is being further analyzed and used in downstream experiments.  
While the CIDAR MoClo standard does enable rational design, 
improvements could be made to increase modularity and consistent expression. 
The Weber and MoClo-YTK (yeast) protocols use linker or connector parts to flank 
the transcription unit and increase modularity. This has a benefit of reducing the 
number of part types required in the library for the same number of permutations. 
Additionally, this modularity further constrains expression variation by 
standardizing the sequence 5’ of the promoter region. To improve modularity in 
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this fashion with the CIDAR MoClo assembly standard, a 5th and 6th part type could 
be created which would flank the 5’ and 3’ ends to remove the need for variable 
promoter and terminator parts. Instead, all promoters would use A as a 5’ fusion 
site, further controlling expression variations, and all terminators would end in a 3’ 
E site.  
3.3.6 Applications of MoClo in traditional biological research and synthetic biology 
With interchangeable parts and the ability to multiplex assembly, MoClo has 
applications as a time and cost efficient means of library creation and propagation, 
mutagenesis screening, transcription factor characterization, protein engineering, 
and genomic engineering. In order to demonstrate this utility, in Chapter 4 we 
collaborated with a biology lab and employed CIDAR MoClo and experimental data 
from Figure 3-3 and Figure 3-4 to balance protein levels with a dual expression 
plasmid. In Chapter 5, MoClo was used to build modular sensors and cellular logic 
gates with plasmids designed to induce a change in pH upon induction. This pH 
signal can be read with affordable open-source electronic devices to create 
bioelectronic sensors and logic devices.  
3.3.7 CIDAR MoClo as an educational tool 
The simplified concept of CIDAR MoClo (two antibiotic, one color, shorter 
protocols) lends itself to an educational setting with the potential for biology 
practice lab protocols being developed to use the CIDAR parts and protocols. 
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These materials are being developed and will be available at 
http://cidarlab.org/moclo.  
3.4 Conclusions 
This work describes the construction of the first bacterial multipart modular 
DNA part library for use in bacteria and the development of optimized MoClo 
assembly protocols and standards. This library and standard lays the groundwork 
for a wide range of synthetic biology applications, greatly increasing efficiency and 
modularity in bacterial engineering. The CIDAR MoClo Library, especially when 
combined with a related design tool (Appleton et al. 2014), allows for rapid 
assembly of synthetic gene networks and cost efficient combinatorial assembly.  
The publicly available CIDAR MoClo Library is intended to provide a starting 
point for research labs to adapt for use in specific fields through the inclusion of 
new DNA parts. It is a flexible assembly standard, allowing for multiplexing, and 
the addition of new part types, new fusion sites, and the streamlined assembly of 
fusion proteins. It is also ideal for academic research and educational uses in 
teaching laboratory settings (Appendix C). 
Though formatted for cloning in E. coli, iterative design of eukaryotic circuits 
is also possible through the introduction of species specific parts. Bio-design 
automation activities are further promoted with the available Eugene design files 
that capture not only the parts in the library but also initial design guidelines and 
data (Appendix D).  
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The CIDAR MoClo Library is available through Addgene 
(www.addgene.org/cloning/moclo/densmore) and additional individual plasmids 
along with functional information and DNA sequence are publicly available through 
the CIDAR ICE Public Registry (www.cidar-ice.org). 
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4 CHAPTER 4 RATIONAL DESIGN WITH CIDAR MOCLO EQUALIZES 
PROTEIN EXPRESSION OF TWO ALDOLASE VARIANTS IN E. COLI TO 
ENABLE ISOLATION OF HETEROTETRAMERS 
4.1 Introduction 
To demonstrate the utility of the CIDAR MoClo Library, we have 
collaborated with the Tolan lab (Biology, Boston University) to tune expression of 
two variants of rabbit aldolase protein, HRA (His-tagged wildtype) and R42A (actin-
binding-deficient mutant). Aldolase, well studied for its role in glycolysis, is only 
found in nature in an unusually stable homotetramer and is known to bind F-actin 
providing a scaffold for actin crosslinking. This crosslinking of actin fibers creates 
a disordered matrix unsuitable for crystalizing, preventing characterization of the 
actin-aldolase interface. HRA:R42A tetramers in which only HRA is able to bind 
actin may enable crystallization by preventing crosslinking (Figure 1-4). Attempts 
at isolating these heterotetramers from dual expression strains have not been 
successful, due to low expression of HRA caused by the 5’ His-tag. Using the 
CIDAR MoClo library and previous expression data, a series of dual expression 
plasmids were created and evaluated. Of these, two show equal expression of 
each aldolase variant by western blot analysis and are being applied to 
crystallization studies.  
We tested the predictive engineering capability of the CIDAR MoClo system 
by producing a dual expression plasmid with two variants of the rabbit aldolase 
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protein expressed constitutively in equal quantities to enable the isolation of 
heterotetramers. These heterotetramers, dimers of dimers, will be used for 
electron microscopy to characterize actin-aldolase binding.   
4.2 Results 
4.2.1 Predictive design of aldolase Transcription Units 
Using the data gathered in Chapter 3 on GFP and RFP expression 
(Figure 3-3c, Figure 3-4, Figure 3-5 and Appendix A) as a reference, a small 
number of promoter:RBS combinations were chosen which were predicted to 
express a goi in similar molar quantities. Single expression units for each aldolase 
variant were created, sequence verified, and assembled into dual expression 
plasmids for the isolation of heterotetramers (Figure 4-1).  
Five contexts were chosen for high equimolar expression of R42A and HRA 
in E. coli, J06B12X_AE, J07B2X_AE, J07B12X_AE, J02B2X_EF, and 
J02B12X_EF. The _EF vector context tends to have lower expression of a given 
transcription unit compared to the same construct in an _AE vector. As expression 
in the _EF transcription unit is the limiting factor for _AF dual expression devices, 
the highest expression contexts in _EF which showed consistency in previous data 
were chosen to enable the highest overall expression levels. Three _AE constructs 
were chosen to match these _EF plasmids in expected expression.  
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Figure 4-1 Plasmid design for aldolase dual expression devices. HRA transcription units are 
pJ06B12HRA_AE(K), pJ07B2HRA_AE(K), pJ07B12HRA_AE(K), pJ02B2HRA_EF(K), 
pJ02B12HRA_EF(K) and designated Tolan-1 through Tolan-5 respectively. The HRA transcription 
units are pJ06B12R42A_AE(K), pJ07B2R42A_AE(K), pJ07B12R42A_AE(K), 
pJ02B2R42A_EF(K), pJ02B12R42A_EF(K) and nicknamed Tolan-6 through Tolan-10 
respectively. The _AE(K) plasmids will be the first transcription unit in each dual expression 
cassette while the _EF(K) plasmids fill the second position. Each combination of pJXBXHRA_AE 
and pJXBXR42A_EF were combined to create the dual expression cassettes expressing HRA 
upstream of R42A. Likewise, each combination of pJXBXR42A_AE and pJXBXHRA_EF were also 
created for a combined total of twelve _AF(A) duel expression plasmids. 
J23102 is consistently the highest strength promoter in the CIDAR MoClo 
library. Likewise, BCD2 and BCD12 have been shown to be the strongest RBS 
parts in the library with BCD2 the stronger of the two by a small margin. The 
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pJ02B2X_EF and pJ02B12X_EF fluorescent reporters produced RFP and GFP in 
similar quantities (Table 4-1).  
Context GFP RFP 
pJ06B12X_AE(K)   7764 ± 420 11165 ± 1112 
pJ07B2X_AE(K)   7400 ± 404   8331 ± 981 
pJ07B12X_AE(K)   8363 ± 159 17987 ± 837 
pJ02B2X_EF(K)   5656 ± 248 13402 ± 1284 
pJ02B12X_EF(K)   5924 ± 55 11530 ± 73 
Average for goi   7021 ± 1179 12483 ± 3572 
   
   
pJ02B2X_AE(K) 29470 ± 2559 50955 ± 2861 
pJ142mX_AE(K)     194 ± 10     178 ± 7 
All values noted as MEFL units of the geometric mean  
± standard deviation measured by flow cytometry.  
 
pJ02B2X_AE(K) and pJ142mX_AE(K) are shown here 
to demonstrate the range of expression 
 
Table 4-1 Fluorescent protein expression data for each genetic context used in aldolase 
tuning. This data was used to model expression of aldolase expression plasmids.  
4.2.2 Protein expression analysis of dual expression plasmids 
HRA_CD and R42A_CD parts were cloned by PCR using template provided 
by the Tolan lab. Transcription units composed as described above were 
assembled with standard CIDAR MoClo protocols in DVK_AE and DVK_EF 
vectors. Upon sequence verification these were further compiled into dual 
expression plasmids (Tolan 1-9, Tolan 1-10, etc. as described in Figure 4-1) in 
DVA_AF vectors. Sequence verified dual expression plasmids were provided to 
the Tolan lab for expression analysis. 
Due to the high degree of similarity between HRA and R42A, accurate 
quantification of each variant in a dual expression system is difficult. Previous data 
(Figure 3-5a) of fluorescent protein reporters suggests expression of a given 
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transcription unit when expressed alone or in a dual expression vector is 
unchanged as long as the same backbone is used. To provide an option for a proxy 
measurement of protein expression in single gene cassettes, individual 
transcription units were subcloned from the standard DVK_AE and DVK_EF 
vectors into DVA_AE and DVA_EF vectors respectively to produce Tolan-1(A) 
through Tolan-10(A).  
Western blots with α-His antibody which recognize HRA but not R42A show 
high levels of HRA expression in all dual expression plasmids (Figure 4-2a) when 
compared to the control. Increasing HRA expression is the first step to creating 
equal dual expression plasmids. Importantly, expression of HRA appears fairly 
consistent between pairs of plasmids containing the same HRA transcription units 
(2-9 and 2-10, 6-5 and 7-5 for example). This same antibody used with single 
expression DVA plasmids showed less consistent expression, contrary to 
expectation, with Tolan-4(A) demonstrating the highest level of expression 
(Figure 4-2b). This inconsistency may be due in part to signal saturation in 
Figure 4-2a.  
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Figure 4-2 Western blots of aldolase protein expression. (a) α-His antibody, expression of HRA 
in each of the dual expression clones is higher than the control demonstrating an improvement 
upon the previous plasmid design. Additionally, pairs of plasmids containing identical HRA TUs 
show similar expression (2-9 and 2-10, 3-9 and 3-10, 6-5 and 7-5), consistent with the fluorescent 
data for these genetic contexts. (b) Expression of HRA in the single TU DVA plasmids show less 
consistent expression of individual TUs with Tolan-4A showing the highest expression of HRA. 
Western blots were performed by Quinn Ho, Tolan Lab. 
Westerns performed on dual expression plasmids using anti-aldolase 
antibodies identify both aldolase variants resulting in doublet bands. Though faint, 
multiple samples appear to have approximately equal expression of HRA and 
R42A when probed with α-aldolase antibody, namely 3-9, 6-4, and 6-5 
(Figure 4-3a). A second western performed with α-aldolase A antibody replicates 
these results with 6-4 and 6-5 showing the highest levels of expression for each 
variant in approximately equal quantity (Figure 4-3b).  
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Figure 4-3 Expression analysis of aldolase HRA and R42A. (a) α-aldolase antibody binds to 
both HRA and R42A presenting a doublet. Bands are faint, yet a few samples appear to contain 
approximately equal quantities of HRA and R42A (3-9, 6-4, 6-5, 7-4). (b) A second α-aldolase 
antibody, α-aldolase A, shows similar results with clearer bands. Of these, 6-4 and 6-5 appear to 
have the highest expression while presenting approximately equal signals for both variants. 
Western blots were performed by Quinn Ho, Tolan Lab. 
4.2.3 GFP and RFP fusion proteins as proxy expression measurements 
A recent publication (Mutalik et al. 2013a) demonstrated the effect of 
various 5’ coding sequences on protein expression by creating fusion proteins 
carrying the 5' 36-nt of a given gene fused to the 5’ end of GFP or RFP under the 
control of a standard promoter and a series of ribosome binding sites. From this 
we hypothesized that fusion proteins carrying the 5’ 36-nt of each aldolase variant 
could substitute as proxy measurements for expression levels of HRA and R42A 
in non-fusion plasmids. This information could inform on the expression patterns 
of the dual expression plasmids previously created as Figure 3-5 demonstrated 
the consistency of expression in a given context when assembled into a multi-TU 
device.  
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Fluorescent fusion proteins of HRA:GFP, HRA:RFP, R42A:GFP and 
R42A:RFP were created to match Tolan-1 through Tolan-10 in terms of promoter, 
RBS and vector context. These were grown overnight along with the same 
contexts with GFP and RFP coding sequences for comparison (pJ06B12X_AE(K), 
etc. as described in Figure 4-1). Fluorescence of each clone was measured in 
triplicate with a Tecan plate reader.  
As the BCD elements are designed to minimize variation in expression due 
to RBS:CDS interaction, it was expected that expression of a given context would 
remain fairly constant with the change of goi between GFP, HRA:GFP and 
R42A:GFP or between RFP, HRA:RFP, and R42A:RFP. However, it appears the 
5’ His-tag in HRA:GFP and HRA:RFP has more influence on gene expression than 
can be ameliorated with the BCDs.  
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Figure 4-4 Fluorescence data of aldolase proxy plasmids. Evaluating fluorescent protein fusion 
proteins as a proxy measurement of HRA and R42A expression. Error ranges are too narrow to be 
visible at this scale.  
This fluorescence analysis does appear to correlate with the western data 
presented in Figure 4-2 and Figure 4-3, with HRA fusions fluorescing at notably 
lower levels (variance of 11.83-fold between R42A:GFP and HRA:GFP units). RFP 
comparisons are more closely related with an average variance of 2.47-fold 
between R42A:RFP and HRA:RFP. Overall, while some information can be 
discerned from the fusion proteins, the reliability of this method as a means of 
evaluation expression of a native protein is uncertain.  
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Considering that the BCDs have been shown previously to reduce variance 
10-fold (Mutalik et al. 2013a), this suggests that expression of HRA without the 
influence of a BCD could be as much as 40-fold less than the R42A equivilant. 
With a BCD present the average variance between HRA:GFP and GFP TUs = 
4.40-fold; variance between HRA:RFP and RFP TUs = 1.74-fold.  
4.3 Discussion 
4.3.1 Balanced expression of both aldolase variants in a single plasmid 
While a more exhaustive approach could be employed in tuning expression 
in a system like the one demonstrated in this chapter, it does appear that we have 
succeeded at engineering equimolar expression within approximately a 2-fold error 
(estimated from western data) in 4 of the 12 dual expression plasmids created. 
Further quantification is pending optimization of protein separation methods. The 
strongest of these (Tolan-6-4 and Tolan-6-5) are currently being applied to 
structural analysis of the aldolase-actin binding interface.  
The concept behind using fusion proteins as proxy measurements has 
some merit, however more analysis is needed. For example, data shown in 
Figure 4-4 was gathered with a plate reader and represents population readings. 
Flow cytometry data of these cells may indicate multiple distinct populations within 
a single culture that could skew mean fluorescence values in a combined 
population. Additionally, more analysis could be performed to determine the length 
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of the 5’ sequence that provides the most accurate representation of expression 
with the native CDS. 
4.3.2 Limiting factors 
The influence of the fusion site choice on expression created an upper limit 
of expression available for dual expression plasmids as even the highest strength 
combination of promoter and RBS in an _EF(K) vector would be approximately 3-
fold weaker than the counterpart _AE(K) vector. Adaptation of the CIDAR MoClo 
assembly standard to include outside linkers or connectors as described for other 
MoClo standards could solve this limitation. Addition of linkers would allow for the 
standardization of the fusion sites directly flanking the transcription unit and 
facilitate the use of the same strong fusion site context with both TUs. 
4.3.3 Alternative design strategies 
The His-tag is a necessary component of downstream experiments 
regarding the isolated aldolase heterotetramers. However, it is likely unnecessary 
for the His-tag to be fused to the 5’ end of the coding sequence rather than the 3’ 
end where it would have less influence on gene expression (Goodman et al. 2013). 
Other tags may provide similar functions and have less influence on protein 
expression.  
Inducible, rather than constitutive, expression also offers an alternative 
approach by which an inducer molecule could be used to control the expression of 
each variant. This approach would minimize the number of genetic designs 
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required and may reduce stress upon the cells caused by constitutive high 
expression of foreign proteins. However, careful control of induction protocols 
would be required and results may not be as consistent as with constitutive 
expression plasmids.   
Another alternative may be to engineer a dimer-of-dimer fusion protein in 
which R42A and HRA are encoded as a single coding sequence, a fusion protein, 
to facilitate 2:2 ratios in heterotetramer formation. The choice of linker domains 
between the subunits would be critical, and other stochastic or structural issues 
may arise from the forced ratio. Such alternatives should be considered, however, 
if this dual expression plasmid and isolation of the correct heterotetramers proves 
to be unfruitful.  
4.4 Conclusions 
In summary, in Chapter 4 we have successfully tuned the expression of two 
variants of a rabbit aldolase protein by selecting genetic contexts based on 
previous expression data. Of the twelve dual expression plasmids examined, four 
appear to have approximately equal expression of both variants for a success rate 
of 33% in terms of balancing expression. Of these, two demonstrate both equal 
and high levels of protein expression (Tolan-6-4 and Tolan-6-5). These are 
undergoing further quantitative analysis and being applied to protein electron 
microscopy experiments to decorate F-actin and determine the actin-aldolase 
binding interface.  
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5 CHAPTER 5 DEVELOPMENT OF BACTERIAL BIOELECTRONIC LOGIC 
GATES WITH pH AND FLUORESCENCE AS OUTPUT SIGNALS 
5.1  Introduction 
A modular DNA assembly system lays the groundwork for a wide variety of 
applications from cell-free expression of combinatorial designs to rapid prototyping 
of bioelectronic sensors. Here we used CIDAR MoClo assembly to create plasmids 
containing DNA circuits which utilize a sugar input and a pH change as an output 
signal. Hydrolysis of lactose by beta-galactosidase reduces pH through the release 
of a hydrogen ion when breaking the bond between a galactose and glucose 
molecule.  
Induction of LacZα expression decreases pH as measured by an Atlas 
Scientific pH probe. pH data is recorded by a Raspberry Pi processor. A change 
in pH can be used as a signaling mechanism to integrate biological inputs into 
digital outputs. Multiple pH probes attached to Raspberry Pi processors facilitate 
the development of bioelectronic Boolean logic gates based on previously 
published genetic designs (Tamsir et al. 2011).  
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Figure 5-1 pH Experiment Schematic. Inducer in the media turns on LacZα, expressing beta-
galactosidase enzyme which metabolizes lactose resulting in an increase of hydrogen ions.  This 
reduction in pH is measured with an Atlas Scientific pH probe attached to a Raspberry Pi. The 
Raspberry Pi reports pH every three seconds until a predetermined threshold is reached. Upon 
reaching threshold, a signal is sent via the Twitter API and a tweet is posted online. This tweet 
triggers the next stage when the signal is received by another Raspberry Pi which controls a 3D 
printed syringe pump calibrated to inject 100 µL of a second inducer molecule into inducible YFP 
expression cells.  
5.2 Results 
5.2.1 Induction of LacZ mediated pH change 
Two plasmids were evaluated as inducible pH circuits, 
pBADLacZDV:J024mAraC_AF(A) and pR10mLacZDV_AE(K) (Figure 5-2). To 
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evaluate the ability to measure a distinct change in pH with lactose induction, a 
dosage response curve was done using pR10LacZDV_AE(K), a modularly 
assembled form of the DVK_AE destination vector. This plasmid contains an 
interchangeable promoter (R0010_AB, pLac) and combined RBS, CDS, and 
terminator LacZDV_BE. This modularity allows for the simple creation of multiple 
LacZ induction plasmids by varying the promoter part.  
 
Figure 5-2 LacZ under the control of pBAD and AraC (above) and R0010m (below). Top: 
pBADLacZDV:J024mAraC_AF(A). Bottom: pR10mLacZDV_AE(K) These constructs allow for 
inducible pH reduction. 
In Figure 5-3, DH5α cells were grown overnight in the presence of lactose 
and pH was measured at 14 hours. Under these conditions, a significant change 
in pH was seen with induction of 50 µM lactose (Figure 5-3) with 
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pR10LacZDV_AE(K) in DH5α cells. As this appears to be a saturating 
concentration, an induction curve was performed to determine whether a lower 
dose would suffice. The resulting curved showing saturation between 25 and 50 
mM (data not shown); therefore a 50 mM induction concentration was used for the 
next round of experiments.  
In order to mimic the logic gates presented in by the Voigt lab (Tamsir et al. 
2011), we transformed the plasmids into TOP10 cells, a DH10B strain. The 
previous experiment was then replicated with pR10m controlling LacZ expression 
as a control and pBAD with arabinose induction as a new circuit (Figure 5-2). This 
data failed to replicate the results (Figure 5-4), with 50 mM of lactose failing to 
decrease pH with pR10m as drastically as seen previously. Additionally, 
expression of LacZα under the control of pBAD and AraC demonstrates a dramatic 
change in pH in the presence of arabinose alone.    
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Figure 5-3 Induction of pH change using lactose and pLac promoter driving LacZa in DH5a 
cells. pR10mLacZDV_AE(K) differs only slightly from pR10LacZDV_AE(K), containing additional 
basepairs to match the DVK_AE sequence. Cells grown overnight (14h) in the presence of lactose.  
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Figure 5-4 pH response with pBAD controlled LacZ expression. DH10B cells were grown 
overnight (14h) in the presence of lactose. pBAD controlled LacZ expression shows pH change in 
response to arabinose alone. Additionally, R10m controlled LacZ expression fails to induce a 
substantial shift in pH with a 50 mM lactose concentration as seen in DH5α cells.     
pH change of the R0010m control is much less substantial in Figure 5-4 
than is seen in DH5α cells. In an attempt to recreate the dramatic pH difference 
between controls and experimental cells, a second induction curve was performed 
with 0, 50, and 150 mM lactose (Figure 5-5). pR10m cells displayed a significant 
change in pH upon induction with 150 mM lactose (p < 0.001). Having recalibrated 
induction for DH10B cells, 150 mM or 200 mM was used in experiments going 
forward.  
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Figure 5-5 Lactose induction curve in DH10B cells. Consistent with Figure 5-4, lactose induction 
appears to be less efficient in DH10B cells, requiring doses of 150 mM or 200 mM (not shown here) 
for substantial decrease in pH.  
All pH experiments to this point were performed as endpoint analyses. To 
determine the effects of incubation time, further induction experiments were 
conducted with pH measured at intervals (Figure 5-6). Cells expressing LacZ 
under the control of pBAD were incubated with or without 0.1% arabinose and 150 
mM lactose. A reduced concentration of arabinose was used in an attempt to 
prevent arabinose mediated pH change. At 7.5 hours, a difference in pH can be 
seen between cells treated with arabinose (pH = 6.67) and those treated with 
arabinose and lactose (pH = 6.00). By tuning LacZ expression in this time course, 
we were able to define the parameters under which pBAD induced LacZα could be 
used as a logic gate component.  
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Figure 5-6 pBAD mediated pH change time course. In order to optimize pBAD mediated pH 
change a time course was performed to observe pH at various intervals. Shorter incubations appear 
to provide a window in which pH is substantially different in in the presence of lactose and arabinose 
when compared to either arabinose alone or no sugar inputs.  
To optimize the induction and pH component of a bioelectronic logic gate, 
we wished to reduce the time required for signal acquisition. To do this, cells were 
grown overnight without inducer or lactose and diluted 1:2 into fresh culture tubes. 
These tubes were then induced and grown for three hours. This three hour protocol 
was sufficient to generate a pH change in R0010m controlled LacZ expression 
cells (p < 0.01) and in pBAD controlled cells (p < 0.01) despite the background 
caused by high arabinose concentration.  
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Figure 5-7 Three hour pH induction protocol. This rapid protocol decreases the time required 
for signal acquisition by decreasing pH in R0010m controlled cells from 7.65 to 6.14 (p < 0.05). 
This experiment was run concurrently with Figure 5-6, using a 1% arabinose induction which is 
seen here to decrease pH in the absence of lactose. Lower concentration is used in the final 
experiment.  
5.2.2 pH mediated induction of Yellow fluorescent protein (YFP) 
A YFP expression plasmid was acquired from the Voigt lab in order to 
closely replicate the logic gates described in Tamir et. al (2011). pOR30, shown in 
Figure 1-5, expresses YFP in the presence of homoserine lactone (HSL) under 
the control of the pLas promoter. Having tuned the expression of the pR10m and 
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pBAD controlled LacZ expression plasmids in the previous experiments, these two 
plasmids were used as the basis of a bioelectronic OR gate.  
An induction curve was performed to determine the concentration of HSL 
necessary to rapidly induce YFP expression in DH10B cells carrying the pOR30 
plasmid. Doses of 10 and 100 mM were analyzed with flow cytometry at 30’ 
intervals from t=0 to t=180. A concentration of __ was selected as an optimal 
induction solution.  
5.2.3 Cellular logic with sugar input, pH intermediate and fluorescent output 
A culture tube containing 200 mM lactose in LB (1 mL) was inoculated with 
500 µL of either pR10mLacZ and or pBADLacZ from an overnight culture. The 
pBADLacZ sample was also induced with 0.1% arabinose. pH probes wired to 
independent Raspberry Pi processors were inserted into each tube. The tubes 
were placed into a shaking incubator and pH was reported every three seconds.  
A 96 well plate containing only controls and one sample well (uninduced 
pOR30 cells in LB) was prepared and the wells covered with breathable film. HSL 
was loaded into the syringe which was placed into the 3D printed syringe pump 
calibrated to inject 100 µL (± 4 µL) at a time. This syringe pump was attached to a 
third Raspberry Pi programmed to monitor the @Tweecoli Twitter account for a 
post reading “True” for a pH change in either culture when pH reached a predefined 
threshold (pH of 5.5).  
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Upon either culture reaching a pH of 5.5, a tweet would be posted live online 
stating either “Lac True at <Date> <Time>” or “Ara True at <Date> <Time>”, 
respectively. Either of these posts would be accepted by the third Raspberry Pi as 
a signal to activate the servo motor in the syringe pump and inject 100 µL of HSL 
into a well containing uninduced cells.  
 
Figure 5-8 pH mediated logic gate with YFP expression output. (a) pH at 30 minute intervals 
of cultures containing DH10B cells with pBADLacZ:J06B2AraC_AF(A) plasmid, induced with 
arabinose (described in Figure 5-2) in media containing 200 mM lactose (blue) and DH10B cells 
with pR10mLacZ_AE(K) plasmid induced with 200 mM lactose alone (red). When pH of either 
sample falls below 5.5, a Tweet is posted via the Twitter API which functions as a trigger for a 
second Raspberry Pi which mediates induction of a fluorescent reporter by controlling the motor 
embedded in a 3D printed syringe pump containing inducer.  (b-e) Fluorescence measurement of 
control and experimental samples from 96 well plate with HSL induction pump demonstrating 
induction of specified well with 2 h. incubation at 37C 900 rpm – (b) DH10B cells, no plasmid, - 
HSL. (c) DH10B cells, no plasmid, + HSL. (d) DH10B cells, pOR30 plasmid, - HSL. (e) DH10B 
cells, pOR30 plasmid, + HSL. 
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Figure 5-8 demonstrates a functioning bioelectronic logic gate in which a 
biological input (sugar) is measured via a pH change and transmitted as a digital 
output (Twitter) which in turn triggers a mechanical input mechanism (HSL 
injection) inducing YFP expression as a biological output. This experiment was 
designed to mimic a previously published logic gate (Tamsir et al. 2011) to 
demonstrate the utility of MoClo in the development of bioelectronic cellular logic. 
While this proof of concept experiment is relatively simple, it lays the groundwork 
for more complex forays into bioelectronic engineering.  
5.2.4 CNC milled 96-well plate adaptions for customized cellular growth and 
analysis experimentation 
Computer numerical control (CNC) milling offers a wide range of 
applications in synthetic biology.  In order to lay basic groundwork for ongoing 
development of CNC milled devices in the CIDAR lab, we have performed 
preliminary analysis of growth and fluorescence measurement capabilities in 
polycarbonate devices (Figure 5-9). Cells grown overnight in 100 µL of LB in this 
5x5 PCA well array had an OD600 of 0.7 and showed normal fluorescence 
patterns with only pJ02B2Rm_AE(K) registering on the red channel and both 
pJ02B2Rm_AE(K) and pJ02B2Gm_AE(K) registering on the green channel with 
the red expression cells showing normal autofluorescence.  
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Figure 5-9 CNC milled 96-well plate adaptation for customized cellular growth and analysis 
experimentation. Polycarbonate plastic (PCA) can be milled to specification for a wide range of 
purposes. (a) Proof of concept 3D printed 96-well plate frame designed to hold a CNC milled 5x5 
well array to evaluate growth and fluorescence measurements in PCA. OD600 ~ 0.80 after 12 hours 
growth at 37°C 900 rpm. (b) RFP fluorescence was measured on a plate reader with excitation at 
580 nm and emission at 635 nm. (c) GFP fluorescence was measured at 485/535 nm and shows 
some background fluorescence as is common with FITC channel measurements of live cells.  
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5.3 Discussion 
We have successfully built and tested a bioelectronic OR gate with pBAD 
and R0010m mediated LacZ expression vectors. This demonstration provides the 
basis for the development of more complex and more physically compact devices. 
Additionally, preliminary experiments show normal cellular growth and 
fluorescence measurement ability in PCA milled devices.  
 A pLac promoter, R0010m, reliably controls pH of DH5α and DH10B cells 
through expression of LacZα and induction with lactose (50 mM in DH5α, 150-200 
mM in DH10B). pBAD mediated expression of LacZα is more intricate, requiring 
careful moderation of arabinose concentration to avoid triggering a pH change with 
arabinose alone. Induction of cells carrying the pBADLacZDV:J024mC80_AF(A) 
to create a substantial pH change was performed with a 0.1% concentration of 
arabinose and 200 mM concentration of lactose with a peak variance in pH seen 
at or before 7.5 hours.  
pTetLacZDV:J024mC40_AF(A) was also evaluated as an inducible pH 
circuit. This design proved to be even less responsive to inducer than the pBAD 
mediated device. A schematic of this circuit (Figure B-3) and time course induction 
data (Figure B-4) can be found in Appendix B.2. 
Though a previously published biosensor has demonstrated this LacZ-pH 
signaling mechanism (de Mora et al. 2011) the pH induction plasmids evaluated 
here indicate a high amount of noise in biological systems with relation to pH. 
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Growth, optical density, and other metabolic pathways influence pH as seen with 
the data in this chapter in which pH of uninduced cultures shifts over time and 
arabinose alone triggers a change in pH. Though pH may be a viable bioelectronic 
interface signal, other interface methods should also be considered moving 
forward.  
Polycarbonate plastic (PCA) can be milled to specification for a wide range 
of purposes and was shown here to be a viable option for containment of cells 
during growth and fluorescence analysis. Thickness of the bottom surface through 
which OD and fluorescence measurements were made was kept standard at 3 
mm. Under the conditions reporter here, growth and fluorescence measurement 
appear normal compared to using standard 96 well plates.  
RFP fluorescence was measured on a plate reader with excitation at 580 
nm and emission at 635 nm. GFP fluorescence was measured at 485/535 nm and 
shows some background fluorescence as is common with FITC channel 
measurements of live cells. In both cases readings were taken from the bottom of 
the plate and a gain of 87 (red) and 89 (green) was used as determined by the 
“optimal gain” option on the Tecan plate reader.  
The applications of 3D printed and CNC milled custom devices in biological 
sciences is infinite, with potential uses including small tools like the syringe pump 
and milled microfluidics as well as larger scale applications in bioproduction and 
metabolic engineering. By producing micromilled devices designed to fit within a 
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96 well plate frame as shown in Figure 5-9 many measurement and analysis tools 
are readily adaptable to custom formats. For example, centrifugal fluidic devices 
which work by spinning a flat plastic disc to move liquid through channels, can be 
cut to fit within a 96 well plate with “output” wells aligned for use in a plate reader 
or other 96-well compatible equipment. Further research into such practices is 
ongoing in the CIDAR lab.   
5.4 Conclusions  
Though a previously published biosensor has demonstrated this LacZ-pH 
signaling mechanism (de Mora et al. 2011) the pH induction plasmids evaluated 
here indicate a high amount of noise in biological systems with relation to pH. 
Growth, optical density, and other metabolic pathways influence pH as seen with 
the data in this chapter in which pH of uninduced cultures shifts over time and 
arabinose alone triggers a change in pH. Though pH may be a viable bioelectronic 
interface signal, other interface methods should also be considered moving 
forward.  
CNC milled devices have the potential to be infinitely advantageous in the 
development of custom bioelectronic circuits, micromilled microfluidics, and other 
areas of research under the umbrella of synthetic biology. Preliminary analysis 
here demonstrates the ability to use PCA as a chamber for growing cells and 
measuring fluorescence on red and green channels. Further analysis is needed to 
determine the effects of polishing rough surfaces, movement of cell cultures 
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through milled channels, and the ability to measure other fluorescence in other 
wavelengths.  
These bioelectronic sensor experiments, paired with the aldolase 
expression tuning experiments described in Chapter 4 demonstrate the utility of 
CIDAR MoClo in both synthetic and traditional biology research. The CIDAR 
MoClo Library is the first bacterial multipart modular DNA library available. It is the 
hope of the author that these materials allow for the wider adoption of MoClo as a 
research and educational tool.  
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Appendix A – Additional MoClo data 
A.1 MoClo protocol optimization 
In order to determine the optimal buffer and ligase for use with MoClo, an 
array of components was compared. This data represents one transformation 
reaction per line and was used as a preliminary assessment. Zymo cells are 
chemically competent cells produced in house from the Bioline Alpha Select DH5α 
strain. While the Zymo protocol is intended to produce extremely high competent 
cells and negate the need for heat shocking and recovery, this rapid transformation 
protocol works only for isolated plasmids. Both Bioline and Zymo cells were used 
with a standard heat shock protocol as described in Chapter 2. 
Construct Buffer Ligase Cells White Blue % White 
pJ00B2Rm_EF Promega Promega Bioline 118 24 83% 
4 part NEB NEB Bioline 260 50 84% 
  Promega NEB Bioline 740 40 95% 
  NEB+BSA NEB Bioline 374 0 100% 
  Promega Promega Zymo 458 58 89% 
  NEB NEB Zymo 230 42 85% 
  Promega NEB Zymo 164 10 94% 
  NEB+BSA NEB Zymo 208 110 65% 
pJ00B2CAM_EF Promega Promega Zymo 172 2 99% 
4 part NEB NEB Zymo 224 38 85% 
 Promega NEB Zymo 88 28 76% 
  NEB+BSA NEB Zymo 30 5 86% 
pJ00ERCreER_EF Promega Promega Zymo 166 28 86% 
6 part NEB NEB Zymo 66 14 83% 
 Promega NEB Zymo 60 20 75% 
  NEB+BSA NEB Zymo 40 46 47% 
       
Table A-1 Preliminary optimization of MoClo protocols. Initial steps compared NEB 
and Promega ligase reagents and competent cell type. 
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Figure A-1 MoClo cycle and volume optimizations. BMC = basic MoClo, standard assembly 
protocol, 4 part transcription unit. 10 µL reactions with 0.5 µL of restriction enzyme and 25 cycles 
resulted in the highest level of consistent assembly efficiency. Lower enzyme concentration and 
fewer cycles still results in sufficient correct clones despite lowered efficiency.  
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CIDAR MoClo Protocols   
 Step Temp 
Time 
(min)  Reaction Conditions 
Standard Step 1 37°C 1.5  
Basic Part or Device  
(DVA Reactions) 
 Step 2 16°C 3  10 fmol each part 
 Cycle 1-2 x15    1x Promega Ligase buffer 
 Step 3 50°C 5  20 U/rxn T4 Ligase 
 Step 4 80°C 10  10 U/rxn BbsI 
 Total time 82.5   Total Volume: 10 -20uL 
      
     
Transcriptional Unit  
(DVK Reactions) 
Troubleshooting  Step 1 37°C 1.5  10 fmol each part 
 Step 2 16°C 3  1x Promega Ligase buffer 
 Cycle 1-2 x25    20 U/rxn T4 Ligase  
 Step 3 50°C 5  10 U/rxn BsaI 
 Step 4 80°C 10  Total Volume: 10 -20uL 
 Total time 127.5   
     Transform 2-5 uL per reaction 
     Either NEB or Promega Ligase 
Rapid Step 1 37°C 20   
 Step 2 37°C 1.5   
For new basic parts Step 3 16°C 3   
 Cycle 2-3 x5-10     
 Step 4 50°C 5   
 Step 5 80°C 10   
 Total time 37.5-60   
 
Table A-2 CIDAR MoClo Protocols as published in ACS Synth Biol 2015. 
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Fusion site choice is crucial for maintaining high efficiency with MoClo. 
Table A-3 acts as a guide for designating new sites. Assigned sites are indicated 
in green with the reverse complement of these sites highlighted orange. Pink 
sequences have only a 1 base pair variation from one or more previously 
designated fusion sites and may cause a decrease in efficiency if used with these 
sites. Red sequences are either repetitive or palindromic and should be avoided 
at all times.  
A.2 Primers for CIDAR MoClo parts and vectors 
Primer Sequence 
Part Forward 5'ATGAAGACGTnnnn-20nt- 
Part Reverse 5'ACGAAGACCTnnnn-20nt- 
  
DV0/DV2/DVA 
Forward 
5'GTACTAGTGGGTCTCAnnnnATGTCTTCtgcaccatatgcggt 
DV0/DV2/DVA 
Reverse 
5'CTACTAGTAGGTCTCTnnnnACGTCTTCcccgcgcgttggccgat 
  
DV1/DVK 
Forward 
5'GTACTAGTGGAAGACATnnnnAGAGACCtgcaccatatgcggtgtgaaatac 
DV1/DVK 
Reverse 
5'CTACTAGTAGAAGACATnnnnAGAGACCcccgcgcgttggccgattcattaa 
   
 Table A-4 Primer design strategy for new basic parts and vectors. At least 20 
nucleotides of annealing part sequence is suggested for creation of new basic parts. 
CDS annealing sequence begins with the second codon as the “ATG” codon is included 
in the C fusion site. Sequences are color coded; red = BbsI, blue = BsaI, grey = SpeI, 
green ‘nnnn’ = fusion site in forward orientation, brown ‘nnnn’ = reverse compliment of 
fusion site.  
 
A.3 Parts for 3Ab CIDAR MoClo part collection (initial) 
Vector Level Antibiotic 5' Flanking Region (5' to 3') 3' Flanking Region (5' to 3') 
DVL0_AB 0 CAM GGTCTCAGGAGATGTCTTC GAAGACGTTACTAGAGACC 
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Vector Level Antibiotic 5' Flanking Region (5' to 3') 3' Flanking Region (5' to 3') 
DVL0_BC 0 CAM GGTCTCATACTATGTCTTC GAAGACGTAATGAGAGACC 
DVL0_CB 0 CAM GGTCTCAAATGATGTCTTC GAAGACGTTACTAGAGACC 
DVL0_CD 0 CAM GGTCTCAAATGATGTCTTC GAAGACGTAGGTAGAGACC 
DVL0_CI 0 CAM GGTCTCAAATGATGTCTTC GAAGACGTTCTAAGAGACC 
DVL0_CX 0 CAM GGTCTCAAATGATGTCTTC GAAGACGTCGTTAGAGACC 
DVL0_CY 0 CAM GGTCTCAAATGATGTCTTC GAAGACGTTGTGAGAGACC 
DVL0_D1E 0 CAM GGTCTCAGTTCATGTCTTC GAAGACGTGCTTAGAGACC 
DVL0_DC1 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTGATGAGAGACC 
DVL0_DC2 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTTATGAGAGACC 
DVL0_DE 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTGCTTAGAGACC 
DVL0_DF 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTCGCTAGAGACC 
DVL0_DG 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTTGCCAGAGACC 
DVL0_DH 0 CAM GGTCTCAAGGTATGTCTTC GAAGACGTACTAAGAGACC 
DVL0_EB 0 CAM GGTCTCAGCTTATGTCTTC GAAGACGTTACTAGAGACC 
DVL0_FB 0 CAM GGTCTCACGCTATGTCTTC GAAGACGTTACTAGAGACC 
DVL0_GB 0 CAM GGTCTCATGCCATGTCTTC GAAGACGTTACTAGAGACC 
DVL0_ID 0 CAM GGTCTCATCTAATGTCTTC GAAGACGTAGGTAGAGACC 
DVL0_XD 0 CAM GGTCTCACGTTATGTCTTC GAAGACGTAGGTAGAGACC 
DVL0_XY 0 CAM GGTCTCACGTTATGTCTTC GAAGACGTTGTGAGAGACC 
DVL0_YD 0 CAM GGTCTCATGTGATGTCTTC GAAGACGTAGGTAGAGACC 
       
DVL1_AE 1 KAN GAAGACATGGAGAGAGACC GGTCTCTGCTTATGTCTTC 
DVL1_EF 1 KAN GAAGACATGCTTAGAGACC GGTCTCTCGCTATGTCTTC 
DVL1_FG 1 KAN GAAGACATCGCTAGAGACC GGTCTCTTGCCATGTCTTC 
DVL1_GH 1 KAN GAAGACATTGCCAGAGACC GGTCTCTACTAATGTCTTC 
       
DVL2_AF 2 AMP GGTCTCAGGAGATGTCTTC GAAGACGTCGCTAGAGACC 
DVL2_AG 2 AMP GGTCTCAGGAGATGTCTTC GAAGACGTTGCCAGAGACC 
DVL2_AH 2 AMP GGTCTCAGGAGATGTCTTC GAAGACGTACTAAGAGACC 
DVL2_EH 2 AMP GGTCTCAGCTTATGTCTTC GAAGACGTACTAAGAGACC 
     
Table A-5 Destination vectors from 3Ab CIDAR MoClo part collection. Fusion sites are shown 
in purple, BsaI recognition sequences in red, and BbsI recognition sequences in blue. Black 
nucleotides indicate spacers required for appropriate placement of enzyme recognition sequences. 
Spacers can be made of any nucleotide, however standard sequences are used to reduce the 
potential for unintended restriction recognition sequences.   
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Part ID Description Cloned by 
B0015_DE Double terminator SI 
B0015_DF Double terminator SI 
B0015_DG Double terminator SI 
B0015_DH Double terminator TH 
B0030_BC Weiss RBS SI 
B0031_BC Weiss RBS SI 
B0032_BC Weiss RBS SI 
B0033_BC Weiss RBS SI 
B0034_BC Weiss RBS SI 
C0012_CD LacI - repressor CDS EA 
C0040_CD TetR - repressor CDS SI 
C0051_CD cI - repressor CDS MF 
C0062_CD luxR - repressor CDS EA 
C0071_CD rhlR - repressor CDS EA 
C0079_CD lasR - activator CDS MF 
C0080_CD araC - regulator CDS EA 
CyPet_CD Flourescent protein CDS EA 
DsRed_Express_CD Flourescent protein CDS EA 
DVL0_AB Destination vector SI 
DVL0_BC Destination vector SI 
DVL0_CD Destination vector SI 
DVL0_DE Destination vector SI 
DVL0_DF Destination vector SI 
DVL0_DG Destination vector SI 
DVL0_DH Destination vector  
DVL0_EB Destination vector SI 
DVL0_FB Destination vector  
DVL0_GB Destination vector SI 
DVL1_AE Destination vector SI 
DVL1_EF Destination vector SI 
DVL1_FG Destination vector SI 
DVL1_GH Destination vector SI 
DVL2_AF Destination vector SI 
DVL2_AG Destination vector SI 
DVL2_AH Destination vector SI 
DVL2_EG Destination vector  
DVL2_EH Destination vector SI 
DVL2_FH Destination vector  
E0030_CD YFP fluorescent protein CDS SI 
E0040m_CD GFP flourescent protein CDS SI 
E1010m_CD RFP fluorescent protein CDS SI 
E2-Crimson_CD Fluorescent protein CDS EA 
EBFP2_CD BFP fluorescent protein CDS TH 
I13453_FB pBAD promoter  
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Part ID Description Cloned by 
I13458_AF pC promoter and AraC CDS  
iRFP_CD iRFP fluorescent protein CDS TH 
J23100_AB Constitutive promoter MF 
J23100_EB Constitutive promoter MF 
J23101_AB Constitutive promoter MF 
J23101_EB Constitutive promoter MF 
J23102_AB Constitutive promoter MF 
J23102_EB Constitutive promoter MF 
J23103_AB Constitutive promoter MF 
J23103_EB Constitutive promoter SI 
J23104_AB Constitutive promoter MF 
J23104_EB Constitutive promoter MF 
J23105_AB Constitutive promoter MF 
J23105_EB Constitutive promoter MF 
J23106_AB Constitutive promoter MF 
J23106_EB Constitutive promoter SI 
J23107_AB Constitutive promoter MF 
J23107_EB Constitutive promoter SI 
J23108_AB Constitutive promoter MF 
J23108_EB Constitutive promoter MF 
J23109_AB Constitutive promoter MF 
J23109_EB Constitutive promoter MF 
J23110_AB Constitutive promoter SI 
J23110_EB Constitutive promoter MF 
J23111_AB Constitutive promoter MF 
J23111_EB Constitutive promoter MF 
J23112_AB Constitutive promoter MF 
J23112_EB Constitutive promoter MF 
J23113_AB Constitutive promoter TH 
J23113_EB Constitutive promoter MF 
J23114_AB Constitutive promoter MF 
J23114_EB Constitutive promoter MF 
J23115_AB Constitutive promoter SI 
J23115_EB Constitutive promoter SI 
J23116_AB Constitutive promoter SI 
J23116_EB Constitutive promoter SI 
J23117_AB Constitutive promoter SI 
J23117_EB Constitutive promoter MF 
J23118_AB Constitutive promoter SI 
J23118_EB Constitutive promoter MF 
J23119_AB Constitutive promoter SI 
J23119_EB Constitutive promoter SI 
LSSmOrange_CD Fluorescent protein CDS EA 
mAmetrine_CD Fluorescent protein CDS EA 
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Part ID Description Cloned by 
mCitrine_CD Fluorescent protein CDS EA 
mNeptune_CD Fluorescent protein CDS EA 
mOrange_CD Fluorescent protein CDS EA 
R0010_AB pLac promoter EA 
R0010_EB pLac promoter MF 
R0010_FB pLac promoter EA 
R0010_GB pLac promoter EA 
R0040_AB pTet promoter SI 
R0040_EB pTet promoter SI 
R0040_FB pTet promoter SI 
R0040_GB pTet promoter SI 
R0051_AB cI promoter  
R0051_EB cI promoter  
R0051_FB cI promoter  
R0051_GB cI promoter  
R0062_AB luxR pR promoter  
R0062_EB luxR pR promoter  
R0062_FB luxR pR promoter  
R0062_GB luxR pR promoter  
R0063_AB luxR pL promoter MF 
R0063_EB luxR pL promoter MF 
R0063_FB luxR pL promoter EA 
R0063_GB luxR pL promoter EA 
R0071_AB RhlR promoter  
R0071_EB RhlR promoter  
R0071_FB RhlR promoter  
R0071_GB RhlR promoter  
R0079_AB LasR promoter EA 
R0079_EB LasR promoter MF 
R0079_FB LasR promoter EA 
R0079_GB LasR promoter EA 
T-Sapphire_CD Fluorescent protein CDS EA 
   
Table A-6 Parts created as initial 3Ab CIDAR MoClo collection. All basic parts are in DVL0 
backbones (CAM resistance). All DVL vectors are as described in the previous table. Parts with no 
initials in the “Cloned by” column were not verified and archived by the time the new CIDAR MoClo 
standard was developed and parts were moved to a DVA backbone. Note: C0012_CD described 
here contained an illegal BsaI site which was repaired to create C0012m_CD(A) in the new library. 
A.4 Parts for CIDAR MoClo Library (Published version) 
A set of 93 plasmids were submitted to Addgene (#1000000059) 
as described in Chapter 3. Table A-7 describes the parts in the kit along 
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with their individual Addgene catalog number, CIDAR-ICE ID, and 
Benchling location. Additional plasmids can be requested directly from 
the CIDAR lab.  
 115 
 
 
T
a
b
le
 A
-7
 C
ID
A
R
 M
o
C
lo
 L
ib
ra
ry
 p
a
rt lis
t. A
ll b
a
s
ic
 p
a
rts
, v
e
c
to
rs
, a
n
d
 flu
o
re
s
c
e
n
t c
o
n
tro
l p
la
s
m
id
s
 a
re
 lis
te
d
 h
e
re
 w
ith
 th
e
ir 
A
d
d
g
e
n
e
 a
n
d
 C
ID
A
R
-IC
E
 ID
 n
u
m
b
e
rs
 a
n
d
 B
e
n
c
h
lin
g
 lo
c
a
tio
n
. T
h
e
 fu
ll c
o
lle
c
tio
n
 c
a
n
 b
e
 re
q
u
e
s
te
d
 fro
m
 A
d
d
g
e
n
e
 (#
1
0
0
0
0
0
0
0
5
9
). 
 
A
d
d
g
e
n
e
 
C
ID
A
R
-IC
E
B
e
n
c
h
lin
g
C
a
t#
ID
#
(b
e
n
c
h
lin
g
.c
o
m
)
J
2
3
1
0
0
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
0
C
ID
A
R
_
4
9
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/g
S
6
lX
C
3
X
/e
d
it
J
2
3
1
0
0
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
1
C
ID
A
R
_
4
9
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/a
q
8
G
x
p
2
O
/e
d
it
J
2
3
1
0
0
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
2
C
ID
A
R
_
4
9
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/rT
z
q
9
T
o
N
/e
d
it
J
2
3
1
0
0
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
3
C
ID
A
R
_
4
9
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/5
y
n
5
Z
y
6
g
/e
d
it
J
2
3
1
0
2
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
4
C
ID
A
R
_
4
9
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/a
Q
O
L
d
1
x
r/e
d
it
J
2
3
1
0
2
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
5
C
ID
A
R
_
4
9
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/z
O
C
Q
C
6
d
M
/e
d
it
J
2
3
1
0
2
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
6
C
ID
A
R
_
4
9
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/1
p
fiY
4
N
G
/e
d
it
J
2
3
1
0
2
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
7
C
ID
A
R
_
4
9
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/L
m
B
W
T
h
y
t/e
d
it
J
2
3
1
0
3
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
8
C
ID
A
R
_
4
9
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/9
K
E
s
W
q
ta
/e
d
it
J
2
3
1
0
3
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
8
9
C
ID
A
R
_
4
9
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/y
n
o
vZ
B
P
9
/e
d
it
J
2
3
1
0
3
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
0
C
ID
A
R
_
5
0
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/o
Z
S
w
b
W
fi/e
d
it
J
2
3
1
0
3
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
1
C
ID
A
R
_
5
0
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/4
q
w
y
O
9
ja
/e
d
it
J
2
3
1
0
6
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
2
C
ID
A
R
_
5
0
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/riO
8
L
Q
F
W
/e
d
it
J
2
3
1
0
6
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
3
C
ID
A
R
_
5
0
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/ljta
z
4
8
p
/e
d
it
J
2
3
1
0
6
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
4
C
ID
A
R
_
5
0
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/b
8
w
a
z
W
5
M
/e
d
it
J
2
3
1
0
6
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
5
C
ID
A
R
_
5
0
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/U
q
D
Z
k
lx
7
/e
d
it
J
2
3
1
0
7
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
6
C
ID
A
R
_
5
0
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/G
8
o
u
T
flM
/e
d
it
J
2
3
1
0
7
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
7
C
ID
A
R
_
5
0
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/S
G
z
lA
9
lZ
/e
d
it
J
2
3
1
0
7
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
8
C
ID
A
R
_
5
0
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/0
m
S
Z
V
0
L
M
/e
d
it
J
2
3
1
0
7
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
5
9
9
9
C
ID
A
R
_
5
0
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/In
U
ih
b
M
F
/e
d
it
J
2
3
1
1
6
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
6
0
0
0
C
ID
A
R
_
5
1
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/1
m
Q
P
Z
F
tM
/e
d
it
J
2
3
1
1
6
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
6
0
0
1
C
ID
A
R
_
5
1
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/x
q
A
O
8
tJl/e
d
it
J
2
3
1
1
6
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
6
0
0
2
C
ID
A
R
_
5
1
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/o
8
lvrId
J/e
d
it
J
2
3
1
1
6
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
s
titu
tive
)
D
V
A
6
6
0
0
3
C
ID
A
R
_
5
1
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/Y
Y
N
k
G
L
B
V
/e
d
it
R
0
0
1
0
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
4
C
ID
A
R
_
5
1
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/e
tg
7
O
rN
6
/e
d
it
R
0
0
1
0
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
5
C
ID
A
R
_
5
1
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/F
a
m
B
p
s
3
h
/e
d
it
R
0
0
1
0
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
6
C
ID
A
R
_
5
1
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/o
i1
T
0
0
L
0
/e
d
it
R
0
0
1
0
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
7
C
ID
A
R
_
5
1
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/Y
w
6
b
g
P
jg
/e
d
it
R
0
0
4
0
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
8
C
ID
A
R
_
5
1
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/3
R
Y
A
jD
6
u
/e
d
it
R
0
0
4
0
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
0
9
C
ID
A
R
_
5
1
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/S
N
Z
H
R
Im
R
/e
d
it
R
0
0
4
0
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
0
C
ID
A
R
_
5
2
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/n
y
z
V
q
e
k
N
/e
d
it
R
0
0
4
0
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
1
C
ID
A
R
_
5
2
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/4
7
3
M
5
9
P
8
/e
d
it
P
la
sm
id
P
a
rt D
e
sc
rip
tio
n
B
a
c
k
b
o
n
e
 116 
 
 
A
d
d
g
e
n
e
 
C
ID
A
R
-IC
E
B
e
n
c
h
lin
g
C
a
t#
ID
#
(b
e
n
c
h
lin
g
.c
o
m
)
R
0
0
6
3
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
2
C
ID
A
R
_
5
2
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/E
U
F
u
Z
K
H
P
/e
d
it
R
0
0
6
3
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
3
C
ID
A
R
_
5
2
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/P
N
1
V
m
c
W
g
/e
d
it
R
0
0
6
3
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
4
C
ID
A
R
_
5
2
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/x
n
A
9
8
Y
5
U
/e
d
it
R
0
0
6
3
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
5
C
ID
A
R
_
5
2
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/jH
Q
H
w
A
a
D
/e
d
it
I1
3
4
5
3
_
A
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
6
C
ID
A
R
_
5
2
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/H
E
4
jo
K
6
k
/e
d
it
I1
3
4
5
3
_
E
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
7
C
ID
A
R
_
5
2
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/Y
C
8
N
e
y
A
e
/e
d
it
I1
3
4
5
3
_
F
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
8
C
ID
A
R
_
5
2
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/c
4
z
F
w
Y
w
w
/e
d
it
I1
3
4
5
3
_
G
B
B
a
s
ic
 P
a
rt - P
ro
m
o
te
r (C
o
n
tro
lla
b
le
)
D
V
A
6
6
0
1
9
C
ID
A
R
_
5
2
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/i9
Y
C
g
IR
i/e
d
it
B
0
0
3
2
m
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (R
B
S
)
D
V
A
6
6
0
2
0
C
ID
A
R
_
5
3
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/jw
Is
L
D
g
9
/e
d
it
B
0
0
3
3
m
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (R
B
S
)
D
V
A
6
6
0
2
1
C
ID
A
R
_
5
3
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/F
Q
F
a
G
7
8
R
/e
d
it
B
0
0
3
4
m
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (R
B
S
)
D
V
A
6
6
0
2
2
C
ID
A
R
_
5
3
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/k
B
N
Y
D
A
H
o
/e
d
it
B
C
D
1
2
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (B
iC
is
tro
n
ic
 D
e
s
ig
n
 (B
C
D
))
D
V
A
6
6
0
2
3
C
ID
A
R
_
5
3
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/m
U
c
Z
U
q
Jo
/e
d
it
B
C
D
2
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (B
iC
is
tro
n
ic
 D
e
s
ig
n
 (B
C
D
))
D
V
A
6
6
0
2
4
C
ID
A
R
_
5
3
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/jM
8
s
Z
d
R
g
/e
d
it
B
C
D
8
_
B
C
B
a
s
ic
 P
a
rt - R
B
S
 (B
iC
is
tro
n
ic
 D
e
s
ig
n
 (B
C
D
))
D
V
A
6
6
0
2
5
C
ID
A
R
_
5
3
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/8
U
h
D
5
V
a
f/e
d
it
C
0
0
1
2
m
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (T
ra
n
s
c
rip
tio
n
 fa
c
to
r)
D
V
A
6
6
0
2
6
C
ID
A
R
_
5
3
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/1
R
o
p
A
Y
a
I/e
d
it
C
0
0
4
0
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (T
ra
n
s
c
rip
tio
n
 fa
c
to
r)
D
V
A
6
6
0
2
7
C
ID
A
R
_
5
3
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/M
9
u
Z
p
T
O
g
/e
d
it
C
0
0
6
2
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (T
ra
n
s
c
rip
tio
n
 fa
c
to
r)
D
V
A
6
6
0
2
8
C
ID
A
R
_
5
3
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/F
F
y
x
W
iw
T
/e
d
it
C
0
0
8
0
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (T
ra
n
s
c
rip
tio
n
 fa
c
to
r)
D
V
A
6
6
0
2
9
C
ID
A
R
_
5
3
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/F
F
y
x
W
iw
T
/e
d
it
c
re
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (R
e
c
o
m
b
in
a
s
e
)
D
V
A
6
6
0
3
0
C
ID
A
R
_
5
4
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/C
A
X
P
c
a
M
y
/e
d
it
E
0
0
3
0
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (F
lu
o
re
s
c
e
n
t re
p
o
rte
r - Y
F
P
)
D
V
A
6
6
0
3
1
C
ID
A
R
_
5
4
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/c
r1
2
B
V
O
E
/e
d
it
E
0
0
4
0
m
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (F
lu
o
re
s
c
e
n
t re
p
o
rte
r - G
F
P
)
D
V
A
6
6
0
3
2
C
ID
A
R
_
5
4
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/c
j9
1
K
rV
H
/e
d
it
E
1
0
1
0
m
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (F
lu
o
re
s
c
e
n
t re
p
o
rte
r - R
F
P
)
D
V
A
6
6
0
3
3
C
ID
A
R
_
5
4
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/1
A
b
C
v0
0
F
/e
d
it
e
B
F
P
2
_
C
D
B
a
s
ic
 P
a
rt - C
D
S
 (F
lu
o
re
s
c
e
n
t re
p
o
rte
r - B
F
P
)
D
V
A
6
6
0
3
4
C
ID
A
R
_
5
4
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/b
b
k
c
tF
d
r/e
d
it
B
0
0
1
5
_
D
E
B
a
s
ic
 P
a
rt - T
e
rm
in
a
to
r (D
o
u
b
le
 T
e
rm
in
a
to
r)
D
V
A
6
6
0
3
5
C
ID
A
R
_
5
4
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/a
1
c
H
N
D
3
3
/e
d
it
B
0
0
1
5
_
D
F
B
a
s
ic
 P
a
rt - T
e
rm
in
a
to
r (D
o
u
b
le
 T
e
rm
in
a
to
r)
D
V
A
6
6
0
3
6
C
ID
A
R
_
5
4
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/f6
R
a
E
G
2
K
/e
d
it
B
0
0
1
5
_
D
G
B
a
s
ic
 P
a
rt - T
e
rm
in
a
to
r (D
o
u
b
le
 T
e
rm
in
a
to
r)
D
V
A
6
6
0
3
7
C
ID
A
R
_
5
4
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/5
p
F
Y
T
k
S
F
/e
d
it
B
0
0
1
5
_
D
H
B
a
s
ic
 P
a
rt - T
e
rm
in
a
to
r (D
o
u
b
le
 T
e
rm
in
a
to
r)
D
V
A
6
6
0
3
8
C
ID
A
R
_
5
4
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/8
s
t8
vL
lQ
/e
d
it
D
V
A
_
A
B
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
3
9
C
ID
A
R
_
5
4
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/s
lH
k
W
K
6
p
/e
d
it
D
V
A
_
A
E
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
0
C
ID
A
R
_
5
5
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/Jb
q
tviM
A
/e
d
it
D
V
A
_
A
F
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
1
C
ID
A
R
_
5
5
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/N
viiN
L
Ip
/e
d
it
D
V
A
_
A
G
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
2
C
ID
A
R
_
5
5
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/p
P
e
9
2
C
O
5
/e
d
it
D
V
A
_
A
H
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
3
C
ID
A
R
_
5
5
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/ia
Y
D
vlV
2
/e
d
it
P
la
sm
id
P
a
rt D
e
sc
rip
tio
n
B
a
c
k
b
o
n
e
 117 
 
 
A.5 Constitutive promoter and RBS part type characterization 
A
d
d
g
e
n
e
 
C
ID
A
R
-IC
E
B
e
n
c
h
lin
g
C
a
t#
ID
#
(b
e
n
c
h
lin
g
.c
o
m
)
D
V
A
_
B
C
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
4
C
ID
A
R
_
5
5
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/o
7
T
O
rR
O
p
/e
d
it
D
V
A
_
C
D
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
5
C
ID
A
R
_
5
5
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/x
g
d
B
8
Z
n
v/e
d
it
D
V
A
_
D
E
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
6
C
ID
A
R
_
5
5
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/m
tp
M
y
n
x
T
/e
d
it
D
V
A
_
D
F
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
7
C
ID
A
R
_
5
5
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/5
3
W
h
x
b
2
s
/e
d
it
D
V
A
_
D
G
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
8
C
ID
A
R
_
5
5
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/b
Jd
Q
O
w
Z
P
/e
d
it
D
V
A
_
D
H
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
4
9
C
ID
A
R
_
5
5
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/s
G
G
Q
D
A
g
6
/e
d
it
D
V
A
_
E
B
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
0
C
ID
A
R
_
5
6
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/i5
JE
Ih
U
g
/e
d
it
D
V
A
_
E
F
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
1
C
ID
A
R
_
5
6
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/O
lS
B
a
Z
C
j/e
d
it
D
V
A
_
E
G
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
2
C
ID
A
R
_
5
6
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/x
G
e
Y
tb
Z
x
/e
d
it
D
V
A
_
E
H
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
3
C
ID
A
R
_
5
6
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/fn
T
q
h
a
2
S
/e
d
it
D
V
A
_
F
B
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
4
C
ID
A
R
_
5
6
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/3
C
u
Y
w
F
w
U
/e
d
it
D
V
A
_
G
B
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r B
a
s
ic
 P
a
rts
 a
n
d
 D
e
vic
e
s
 A
m
p
ic
illin
)
D
V
A
6
6
0
5
5
C
ID
A
R
_
5
6
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/U
vu
V
a
p
b
V
/e
d
it
D
V
A
D
e
s
tin
a
tio
n
 V
e
c
to
r (B
a
c
k
b
o
n
e
 fo
r n
e
w
 D
V
s
)
D
V
A
6
6
0
5
6
C
ID
A
R
_
5
6
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/6
h
ijq
fvT
/e
d
it
p
J
0
2
B
2
G
m
_
A
E
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
5
7
C
ID
A
R
_
5
6
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/m
g
Y
D
c
L
4
z
/e
d
it
p
J
0
2
B
2
G
m
_
E
F
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
5
8
C
ID
A
R
_
5
6
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/3
W
Q
b
d
lz
U
/e
d
it
p
J
0
2
B
2
R
m
_
A
E
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
5
9
C
ID
A
R
_
5
6
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/K
b
4
A
A
b
o
x
/e
d
it
p
J
0
2
B
2
R
m
_
E
F
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
6
0
C
ID
A
R
_
5
7
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/F
O
M
8
u
x
tS
/e
d
it
p
J
0
2
B
2
G
m
:R
m
_
A
F
D
e
vic
e
 (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
6
1
C
ID
A
R
_
5
7
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/D
7
5
z
iv6
K
/e
d
it
p
J
0
2
B
2
R
m
:G
m
_
A
F
D
e
vic
e
 (F
A
C
S
 C
o
n
tro
ls
)
D
V
A
6
6
0
6
2
C
ID
A
R
_
5
7
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/O
O
k
a
V
w
1
a
/e
d
it
p
J
0
2
B
2
G
m
_
A
E
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
K
6
6
0
6
3
C
ID
A
R
_
5
7
3
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/S
h
V
Jx
D
d
F
/e
d
it
p
J
0
2
B
2
G
m
_
E
F
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
K
6
6
0
6
4
C
ID
A
R
_
5
7
4
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/u
U
T
m
e
fO
7
/e
d
it
p
J
0
2
B
2
R
m
_
A
E
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
K
6
6
0
6
5
C
ID
A
R
_
5
7
5
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/s
y
rZ
c
M
B
4
/e
d
it
p
J
0
2
B
2
R
m
_
E
F
T
ra
n
s
c
rip
tio
n
a
l U
n
it (F
A
C
S
 C
o
n
tro
ls
)
D
V
K
6
6
0
6
6
C
ID
A
R
_
5
7
6
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/n
N
IC
V
G
u
k
/e
d
it
D
V
K
_
A
E
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r T
ra
n
s
c
rip
tio
n
a
l U
n
its
 K
a
n
a
m
y
c
in
)
D
V
K
6
6
0
6
7
C
ID
A
R
_
5
7
7
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/s
u
e
y
p
h
O
w
/e
d
it
D
V
K
_
A
F
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r T
ra
n
s
c
rip
tio
n
a
l U
n
its
 K
a
n
a
m
y
c
in
)
D
V
K
6
6
0
6
8
C
ID
A
R
_
5
7
8
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/1
i0
m
X
4
1
y
/e
d
it
D
V
K
_
E
F
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r T
ra
n
s
c
rip
tio
n
a
l U
n
its
 K
a
n
a
m
y
c
in
)
D
V
K
6
6
0
6
9
C
ID
A
R
_
5
7
9
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/7
F
u
JO
5
tD
/e
d
it
D
V
K
_
F
G
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r T
ra
n
s
c
rip
tio
n
a
l U
n
its
 K
a
n
a
m
y
c
in
)
D
V
K
6
6
0
7
0
C
ID
A
R
_
5
8
0
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/C
z
5
h
Q
9
w
M
/e
d
it
D
V
K
_
G
H
D
e
s
tin
a
tio
n
 V
e
c
to
r (F
o
r T
ra
n
s
c
rip
tio
n
a
l U
n
its
 K
a
n
a
m
y
c
in
)
D
V
K
6
6
0
7
1
C
ID
A
R
_
5
8
1
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/M
F
w
9
p
N
D
U
/e
d
it
D
V
K
D
e
s
tin
a
tio
n
 V
e
c
to
r (B
a
c
k
b
o
n
e
 fo
r n
e
w
 D
V
s
)
D
V
K
6
6
0
7
2
C
ID
A
R
_
5
8
2
h
ttp
s
://b
e
n
c
h
lin
g
.c
o
m
/s
/o
lS
4
2
c
D
R
/e
d
it
P
la
sm
id
P
a
rt D
e
sc
rip
tio
n
B
a
c
k
b
o
n
e
 118 
 
A total of 6 constitutive promoters and 6 RBS parts were selected for 
inclusion in the CIDAR MoClo Library. As described previously, an array of GFP 
expression plasmids was constructed to evaluate the strength of the RBS and 
constitutive promoter parts. Using this data, J23100, J23102, J23103, J23106, 
J23107, and J23116 were selected for the CIDAR MoClo Library along with all 6 
RBS parts tested (B0032m, B0033m, B0034m, BCD2, BCD8, and BCD12). A 
subset of the data presented in Figure 3-6 and Figure 3-7 is shown below for all 
combinations of these 6 promoters and 6 RBS parts. This chart is included to assist 
in selecting promoters and RBS parts in future designs. 
 
Figure A-2 CIDAR MoClo Library – Constitutive promoters and RBS parts, GFP 
expression plasmids. A subset of the data from Figure 3-6 and Figure 3-7, all 
combinations of constitutive promoter and RBS parts which were included in the CIDAR 
MoClo Library are shown here to aid in selection of parts for future designs. 
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A.6 Data tables for Chapter 3 figures 
 GFP RFP 
 Mean GSD+ GSD- Mean GSD+ GSD- 
pJ02B2X_AE(A) 82571 83011 82133 118142 121733 114658 
pJ02B2X_AE(K) 29396 32065 26948 50902 53843 48121 
pJ02B2X_GH(K) 25133 28327 22300 28993 30355 27691 
pJ024mX_AE(K) 22299 22918 21698 31844 34567 29335 
pJ02B12X_AE(K) 16242 17629 14965 33180 39642 27771 
pJ06B2X_AE(K) 12595 12866 12329 33840 36962 30981 
pJ07B12X_AE(K) 8362 8523 8205 17974 18831 17156 
pJ07B2X_AE(K) 7393 7808 7000 8292 9331 7370 
pJ02B2X_FG(K) 8080 8698 7505 5717 5966 5478 
pJ06B12X_AE(K) 7756 8187 7348 11128 12295 10072 
pJ064mX_AE(K) 6169 6318 6025 2062 2265 1878 
pJ024mX_EF(K) 5928 6474 5428 5646 6440 4950 
pJ02B12X_EF(K) 5924 5979 5869 11530 11602 11457 
pJ022mX_AE(K) 5899 6954 5004 3064 3066 3061 
pJ02B2X_EF(K) 5652 5906 5410 13451 14797 12228 
pJ14B12X_AE(K) 4982 5037 4927 10721 14867 7731 
pJ14B2X_AE(K) 4372 4404 4341 11930 15418 9231 
pJ074mX_AE(K) 4089 4475 3737 1284 1530 1077 
pJ02B2X_EF(A) 3953 4070 3840 3273 3363 3185 
pJ144mX_AE(K) 2617 2755 2486 2993 3029 2957 
pJ062mX_AE(K) 1981 2068 1897 1249 1371 1137 
pJ072mX_AE(K) 1124 1188 1063 944 1008 883 
pJ063mX_AE(K) 1119 1123 1115 534 662 431 
pJ06B8X_AE(K) 716 740 692 3696 4538 3010 
pJ073mX_AE(K) 698 742 656 364 404 329 
pJ022mX_EF(K) 498 555 446 315 331 299 
pJ07B8X_AE(K) 401 407 396 2806 2806 2806 
pJ142mX_AE(K) 194 204 184 178 185 171 
 
Table A-8 MEFL units - Geometric mean of fluorescence as displayed in Figure 3-3c. All 
samples were measured in triplicate and data is provided as geometric mean, high, and low. 
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 2CC GFP L1 2CC GFP L2 
 Mean GSD+ GSD- Mean GSD+ GSD- 
pJ02B2 3953 4070 3840 5682 5750 5615 
pJ02B12 4063 4173 3957 2587 2858 2343 
pJ024m 1500 1572 1431 3947 4193 3715 
pJ022m 449 462 436 1423 1440 1406 
pJ14B2 395 429 365 580 617 546 
pJ14B12 465 488 443 343 383 308 
pJ144m 208 212 204 158 159 156 
pJ142m 124 128 121 141 145 136 
       
 2CC RFP L1 2CC RFP L2 
 Mean GSD+ GSD- Mean GSD+ GSD- 
pJ02B2 118142 121733 114658 162270 173731 151564 
pJ02B12 70614 70944 70285 34736 37543 32139 
pJ024m 9618 9804 9436 6217 6540 5910 
pJ022m 3721 3922 3530 7221 7654 6813 
pJ14B2 3429 3595 3270 7422 7470 7375 
pJ14B12 3303 3396 3213 3678 3751 3606 
pJ144m 524 539 508 657 728 594 
pJ142m 152 155 149 216 226 206 
       
Table A-9 MEFL units - Geometric mean of fluorescence as displayed in Figure 3-5a. All 
samples were measured in triplicate and data is provided as geometric mean, high, and low. 
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 Kan Amp 
 Mean GSD+ GSD- Mean GSD+ GSD- 
pJ022mRm_AE 3064 3066 3061 3721 3922 3530 
pJ024mRm_AE 31844 34567 29335 9618 9804 9436 
pJ02B12Rm_AE 33180 39642 27771 70614 70944 70285 
pJ02B2Rm_AE 50902 53843 48121 118142 121733 114658 
pJ142mRm_AE 178 185 171 152 155 149 
pJ144mRm_AE 2993 3029 2957 524 539 508 
pJ14B12Rm_AE 10721 14867 7731 3303 3396 3213 
pJ14B2Rm_AE 11930 15418 9231 3429 3595 3270 
pJ02B2Gm_AE 19733 20775 18743 82571 83011 82133 
pJ02B2Gm_EF 5652 5906 5410 3953 4070 3840 
pJ02B12Gm_EF 5924 5979 5869 4063 4173 3957 
pJ024mGm_EF 5928 6474 5428 1500 1572 1431 
pJ022mGm_EF 498 555 446 449 462 436 
pJ14B2Gm_EF 2513 2831 2230 395 429 365 
pJ14B12Gm_EF 2785 3263 2377 465 488 443 
pJ144mGm_EF 3505 3920 3135 208 212 204 
pJ142mGm_EF 133 134 131 124 128 121 
pJ02B2Rm_EF 13170 13364 12979 3273 3363 3185 
 
Table A-10 MEFL units - Geometric mean of fluorescence as displayed in Figure 3-5b. All 
samples were measured in triplicate and data is provided as geometric mean, high, and low. 
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 _AE _EF 
 Mean GSD+ GSD- Mean GSD+ GSD- 
pJ022mRm(K) 3064 3066 3061 315 331 299 
pJ024mRm(K) 31844 34567 29335 5646 6440 4950 
pJ02B12Rm(K) 33180 39642 27771 11530 11602 11457 
pJ02B2Rm(K) 50902 53843 48121 13451 14797 12228 
pJ062mRm(K) 1249 1371 1137 97 102 93 
pJ063mRm(K) 534 662 431 76 77 75 
pJ064mRm(K) 2062 2265 1878 1732 2013 1489 
pJ06B12Rm(K) 11128 12295 10072 2573 3066 2159 
pJ06B2Rm(K) 33840 36962 30981 2703 3204 2280 
pJ06B8Rm(K) 3696 4538 3010 398 415 381 
pJ072mRm(K) 944 1008 883 93 100 86 
pJ073mRm(K) 364 404 329 75 75 74 
pJ074mRm(K) 1284 1530 1077 1177 1269 1091 
pJ07B12Rm(K) 17974 18831 17156 2522 2717 2341 
pJ07B2Rm(K) 8292 9331 7370 2797 3403 2300 
pJ07B8Rm(K) 2806 2806 2806 364 377 352 
pJ02B2Gm(K) 19733 20775 18743 5652 5906 5410 
pJ02B12Gm(K) 16242 17629 14965 5924 5979 5869 
pJ024mGm(K) 22299 22918 21698 5928 6474 5428 
pJ022mGm(K) 5899 6954 5004 498 555 446 
pJ14B2Gm(K) 4372 4404 4341 2513 2831 2230 
pJ14B12Gm(K) 4982 5037 4927 2785 3263 2377 
pJ144mGm(K) 2617 2755 2486 3505 3920 3135 
pJ142mGm(K) 194 204 184 133 134 131 
       
Table A-11 MEFL units - Geometric mean of fluorescence as displayed in Figure 3-5c. All 
samples were measured in triplicate and data is provided as geometric mean, high, and low. 
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Appendix B Additional experimental information 
B.1 Chapter 4 – Sequence structure of aldolase fusion proteins.  
 
 
 
Figure B-1 Sequence annotation of 5' HRA fusion protein sequence. Full sequence 
analysis available on Benchling. 
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Figure B-2 Sequence annotation of 5' R42A fusion protein sequence. Full sequence analysis 
available on Benchling. 
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B.2 Chapter 5 – pTetLacZDV:p024mC40_AF(A) structure and induction profile.  
 
Figure B-3 pTetLacZDV:J024mC40_AF(A) circuit. This circuit was evaluated for use 
in the pH biosensor experiments but failed to provide a distinctive pH change upon 
induction with anhydrous tetracycline (aTc). 
 
 
Figure B-4 pTet mediated pH induction time course. pTet mediated pH induction 
was less functional as a biosensor than the other circuits tested. Here cells were grown 
in 3 mL cultures and pH was measured at the defined intervals. Earlier time points may 
offer more functionality.  
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Appendix C Education 
CIDAR Educational Labs are found in supplementary files attached to 
this dissertation along with calculation files and an accompanying 
Powerpoint presentation.  
Also hosted on www.cidarlab.org. 
 
Appendix D External files 
Also hosted on www.cidarlab.org. 
D.1 MoClo assembly calculation files in Excel linked to part list.  
CIDARAssemblyCalculations.xlsx 
 
D.2 Raven file containing part list 
raven_CIDARMoCloLibrary.csv 
 
D.3 Eugene file 
CIDAR_MoClo_Eugene_final.eug 
 
Appendix E Development of modular biosensors for allergen detection 
This appendix describes the background and experimental design for a 
bioelectronic whole cell gluten biosensor designed in a modular fashion using 
MoClo and multiplex MoClo protocols. This project was discontinued. Preliminary 
progress is documented here to provide a resource for further study.  
E.1 Two component systems for biosensor development 
Recent work using domain exchange methods have utilized histidine kinase 
two-component systems and focused on the Per-Arnt-Sim (PAS) protein domain 
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family (Gu et al. 2000). PAS sensor domains are ubiquitous across all forms of life 
where they are involved in regulating gene expression in response to various 
inputs including light and oxygen. While the PAS sensor domain of a histidine 
kinase adopts a common globular structure, the effector domains of these proteins 
are often highly varied, functioning as kinases, transcription factors, and 
phosphodiesterases. This allows for a standardized yet versatile signal recognition 
motif with an expansive repertoire of response capabilities. This apparent 
modularity suggests the ability to interchange PAS domains to rewrite the natural 
biosensing pathways towards engineering novel biosensors and create unique 
gene regulatory systems.  
Multiple groups have shown this to be true both in vitro and in vivo primarily 
with LOV domains (Tar:EnvZ (Utsumi et al. 1989) YtlV:FixL (Moglich et al. 2009) 
Cph1:EnvZ (Levskaya et al. 2005, Tabor et al. 2009)). Named for their stimuli, light-
oxygen-voltage (LOV) domains bind flavin nucleotides, inducing an auto-
phosphorylation of the cytoplasmic kinase domain and subsequent transfer of this 
phosphate to a downstream response regulator (Gu et al. 2000). 
Previous research has shown successful domain exchange in histidine 
kinases, primarily in the development of optogenetic tools (Levskaya et al. 2005, 
Moglich et al. 2009, Tabor et al. 2009, Moglich and Moffat 2010) and provided 
insight towards further rearrangements, particularly with respect to the 
characteristics of the required Jα linker domain (Jin and Inouye 1994, Moglich et 
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al. 2009). This linker shows little homology among related TCS yet conserves a 
standard 7(n)-mer or 7(n)+2 pattern. This heptad periodicity is characteristic of α-
helical coiled coil and is required for correct function seemingly by controlling the 
orientation of the sensor and kinase domains as indicated by the lack of function 
in YtvA:FixL chimeric proteins which disrupted this periodicity (Moglich et al. 2009). 
Two papers specifically lay out design constraints for the development of future 
two-component chimeric proteins (Yoshida et al. 2007, Moglich et al. 2009). 
Skerker et al. have also shown the ability to rationally rewire two-component 
systems by mutating specific residues which dictate the interaction of the histidine 
kinase with its cognate response regulator predicted by analyzing the patterns of 
coevolution in two-component systems. By mutating as few as three amino acids 
of the EnvZ kinase domain, T250V, L254Y and A255R, the authors were able to 
show specific phosphorylation of the non-cognate response regulator RstA and 
amelioration of the natural phosphorylation of OmpR (Skerker et al. 2008). The 
independence of protein domains in histidine kinases suggests the possibility of a 
modular recombination method in rewiring the specificity of known two-component 
systems by domain exchange with Multiplex Modular Cloning. Additionally, the 
directed point mutation based rewiring of EnvZ demonstrates the potential for 
rational modification of phosphorylation targets.  
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E.2 Design of a Whole-Cell Rapid Bio-electronic Gluten Detector 
Glutamine binding protein (GlnBP) is a 26 kDa periplasmic E. coli protein 
which, in a monomeric form, is responsible for initializing the active transport of L-
glutamine into the cell. GlnBP has been shown previously to selectively bind 
gliadin, the alcohol soluble component of gluten. This induced the authors to 
design a bioelectronics sensor using purified GlnBP and a nanostructured porous 
silicone (PSi) waver with the mild success of detecting gluten at levels as low as 
2,000 ppm. Regardless of the inadequate sensing capabilities, the cost of purifying 
GlnBP and production of silicone wavers would have been prohibitive of a 
commercial detection kit. This research, however, provides a starting point for a 
synthetic biology approach to developing a gluten biosensor.  
By taking advantage of the natural selective binding of GlnBP to gliadin, the 
simultaneous iterative design methods developed above, and previous research 
upon the modularity of two-component systems, I propose to develop a rapid, 
accurate, sensitive and affordable whole-cell gluten biosensor.  
E.2.1 Development of a “Slow” Gluten Sensor 
The logical first step is the development of a transcription-based gluten-
sensing strain of E. coli through fusion of GlnBP to the transmembrane and 
cytoplasmic domains of EnvZ. All of the following experiments will performed in the 
EnvZΔ strain(Levskaya et al. 2005) of E. coli reported by Levskaya et al. (RU1012 
[MC4100 ara+ φ(OmpC-lacZ) 10-25 ΔenvZ::KanR]) or a derivative strain.   
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E.2.1.1 Experimental Design: GlnBP:EnvZ fusion 
Structural analysis and sequence homology of each family of proteins will 
be used to inform on the most probable position of splicing between these two 
proteins. GlnBP is 224 residues in length and contains two globular domains. The 
cleft formed between the larger domain (a.a. 1-84 and 186-224) and the smaller 
domain (a.a. 90-180) contains the ligand binding site. As such, it is likely the 
complete GlnBP coding sequence will be required for a successful chimeric 
protein.  
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Figure E-1 Whole cell bioelectronic gluten biosensor design. Gluten sensing and phospho-
activated cell lysis systems will be engineered separately using LacZα catalyzed pigmentation and 
OD as measures of gluten binding and lysis respectively. A selectable marker may also be used in 
the screening of GlnBP:EnvZ chimeras. Once calibrated, the two systems will be tuned and 
optimized for use with a bioelectronics interface to provide a digital report. 
The Cph1:EnvZ fusion created by Levskaya et al. used the same C-terminal 
229 a.a. fragment of EnvZ as was previously used in one of the first experiments 
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to demonstrate the modularity of two-component systems by rewiring the aspartate 
sensing Tar and oxygen responsive EnvZ histidine kinases in a similar manner. 
Initial attempts at developing this GlnBP:EnvZ fusion will use this same fragment 
as well as a degenerate linker library based upon the Cph1:EnvZ, Tar:EnvZ and 
YtlV:FixL chimeric protein sequences and extensive analysis histidine kinase linker 
domains included in these publications (Utsumi et al. 1989, Zhu and Inouye 2003, 
Levskaya et al. 2005, Moglich et al. 2009).   
In order to efficiently screen this library of chimeric proteins, the previously 
established reporter system will be used in which activation of OmpR by the 
cytoplasmic domain of EnvZ leads to the expression of LacZα and the 
pigmentation. In order for this screening method to function, a modified destination 
vector which does not use LacZα expression as a screenable marker will be 
required. Affinity of this chimeric protein for gliadin as a whole and the toxic peptide 
specifically will be determined.  
Potential troubleshooting: 
Other species of bacteria may be more appropriate as a biosensor 
especially in later stages of this development. However, as the MoClo library and 
protocols are currently oriented towards work in E. coli, initial attempts will be made 
in this species with a change of chassis as one of the first avenues of adjustment 
should the need arise. While EnvZ has historically been successful in rewiring 
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endeavors, another histidine kinase may be required for successful development 
of a GlnBP:Kinase chimera.  
E.2.2 Post-translational Control of Lysis 
The response regulator portion of the gluten sensor can be developed 
separately alongside the development of the GlnBP:EnvZ chimera. As 
phosphorylation is a common and rapid mechanism of controlling enzyme function, 
engineering phosphorylation (Johnson and Lewis 2001) dependent allosteric 
control of a lytic enzyme may be a viable method of rapidly inducing lysis as a 
response to gluten. Previously successful modular rearrangement of the Yersina 
and T4 phage lysin proteins, effectively rewired specificity (Lukacik et al. 2012) and 
lends support to the engineering of an allosterically controlled T4 lysin chimeric 
protein.  
Once again using a chimeric protein library, composed of the EnvZ cognate 
response regulator OmpR and a bacteriophage lysin protein, I propose to develop 
a phosphosensitive lysin protein which will induce cell lysis upon phosphorylation 
by GlnBP:EnvZ providing a rapid and amplified signal in response to gluten. 
E.2.2.1 Experimental Design: OmpR:Lysin Fusion 
Sequence, structure, host specificity and pathogenicity will factor into the 
selection of a subset of lytic enzymes for use in this design, beginning with the T4 
phage lysin. Informed by the rules and constraints generated in Aim 2 and analysis 
of both structure and sequence conservation in OmpR and the chosen lysin(s), 
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mixed clones of each will be created in a CXD format as described in 2.2.2. Due 
to the use of a lytic enzyme, tight inducible control of expression will be required 
to allow for growth of cells containing this chimeric gene sequence. Additionally, 
as most lysin proteins require the assistance of a second enzyme, a holin, (Young 
1992) to escape the cell membrane, expression of this enzyme could also be used 
as a means of control. Cultures will be grown to early log phase, induced, and 
monitored for changed in OD measured by plate reader to identify continued 
growth versus lysis. As a positive control for lysis, the chosen lysin will be screened 
as well. Ideally, an inactive form of the chosen lysin will also be available.  
Potential troubleshooting:  
Depending upon sequence analysis and the success of the initial round of 
chimeric proteins, different fragments of each protein may be identified and 
attempted. Additionally, internal insertion either protein may provide more 
successful fusions as described in 2.2.2. Preventing non-specific cell death will be 
difficult. Requiring multiple levels of control and may be prohibitive to this design 
strategy. Other means of triggering lysis may need to be considered as well as 
other forms of signal output. Some success has been seen in bioelectronics 
interfaces sensing luciferase (unpublished, Cambridge iGEM 2012) or using the 
metal reducing S. oneidensis to create a measurable charge (unpublished, 
Edinburgh iGEM 2012), though with low sensitivity.  
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E.2.3 Phospho-activated Lysin as the Response Regulator of GlnBP:EnvZ 
If the above experiments are successful, the two cassettes (or collection of 
iterations of each) would be combined in the same cell and screened for function. 
Once completed, lysis becomes an amplified signal for the presence of gluten and 
can be integrated with a bioelectronics interface to provide a digital readout. Such 
bioelectronics interfaces have been shown in the form of proteins fixed to CMOS 
sensors which can detect changes in voltage or pH due to biological stimuli (Ho et 
al. 2007, Manickam et al. 2010, Welch and Christen 2012). Adapting this system 
to detect cell lysis and the accompanied change in voltage would likely be a 
collaborative effort and conversations to this end have been initiated. 
E.2.3.1 Experimental Design: Gluten induced lysis 
As each half of this sense-response system will be engineered in a multiplex 
fashion and screened for function individually, it is possible multiple potential 
iterations of each will be available for further screening in a combined system. 
Assembly at this point is determined by the outcome of the previous experiments, 
but will be performed using MoClo in the most efficient manner possible. 
Adjustments for copy number and adjustments to expression levels may need to 
be performed and it is likely a gnomically encoded system will be required. Once 
a laboratory version of the gluten detection whole-cell biosensor is developed the 
assay will be simplified for use by consumers, ideally through a simple 
bioelectronic integration on par with a standard glucose blood sugar detection 
system.  
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Potential troubleshooting:  
While experiments will begin with OmpR and the T4 lysin protein, different 
molecules may function better in developing ligand-triggered lysis. Success with 
any of the previously proposed chimeric proteins will shed light upon design 
constraints and inform more successful designs, particularly in the case of the 
highly conserved modular histidine kinases. Even if both systems are working 
independently, the larger device may not function as a whole requiring reiterations 
upon the design. Once again, any reiterations will be informed by previous 
attempts and successes.  
E.3 Current Status 
Components of the EnvZ synthetic genetic light detection system were 
acquired from Addgene (pCph8 plasmid, #22869, chloramphenicol resistant) and 
from Dr. J. Clark Lagarias at the University of California – Davis (pPL-PCB plasmid, 
spectinomycin resistant). pPL-PCB contains pcyA and ho1 coding sequences 
under the control of a single promoter (Levskaya et al. 2005). The CP919 strain, 
an MC4100 E. coli derivative, carries a genomic pOmpC promoter driving 
expression of LacZα. CP919 functions as a reporter plasmid for pCph8 (acquired 
from Voigt Lab) and is resistant to both kanamycin and spectinomycin.  
The coding sequences for Cph8, pcyA and ho1 have been converted to 
MoClo CDS parts, designated as Cph8_CD, pcyA_CD and ho1_CD respectively. 
Transcription units containing these coding sequences were created and 
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designated pMAD1 and pMAD2 (ho1), pMAD3 and pMAD4 (pcyA), pMAD5 and 
pMAD6 (Cph8). Co-expression plasmids using pMAD1-4 were assembled and 
designated pMAD7-8 in _AF vectors. These are archived as mini preps and 
glycerol stocks alongside a glycerol stock of CP919.  
Exploration into the bioelectronic aspects of this sensor design led to the 
experiments documented in Chapter 5. In light of those results, while pH can 
function as an electronically integrated signal, there appears to be many 
contributing factors to adjusting pH of biological cultures. This noise may 
necessitate more manageable signal integration approaches.  
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